Concall Notes.
Short editorial briefs on Indian earnings calls. Transcript notes are written from call transcripts; call-monitor notes use Tijori Concall Monitor analysis, credited clearly.
Where management changed its story
Calls where this quarter's guidance appears to contradict a prior call. Source: Tijori Concall Monitor's consistency check, summarised editorially.
-
Chola's liquid assets fell 86% in one quarter, same definition, no explanation
Liquid assets dropped from ₹21,186 crore to ₹2,984 crore sequentially, while management maintained the same disclosure basis. The unexplained swing overshadows otherwise strong AUM growth and asset quality.
Inconsistency Chola reported liquid assets of ₹2,984 crore in July 2026, down from ₹21,186 crore in May 2026 and ₹18,857 crore in February 2026, all explicitly including undrawn sanction lines. The 86% sequential decline was not explained. Separately, the expected CCD conversion timeline slipped: February said July 2026, May said H1 FY27, July now says only ₹200 crore converted in July and ₹430 crore expected in October. Home-loan yield attribution also shifted from ARC accounting in May to normal Q4 seasonality in July, without reconciling the two.Strong operating quarter, but the liquidity mismatch is a disclosure issue that needs urgent fixing.
-
KRT delays delivery, pushes out occupancy gap target
Under-construction assets pushed to FY-end, occupancy gap narrowing delayed to Q4, and ROFO pipeline shrinks 10% — all without explanation.
Inconsistency Under-construction delivery timeline extended from Q2 FY27 to before end-FY27; occupancy gap normalization pushed from 2-3 quarters out to Q4 FY27; ROFO pipeline reduced from 6.7 mn sq ft to 6 mn sq ft with no explanation.Strong leasing numbers can't paper over three unexplained misses on execution. Credibility is now the story.
-
Gallantt Ispat's capacity and mine targets shifted without explanation
The ₹3,000 crore capex plan's incremental capacity was trimmed, captive mines dropped from four to three, and solar scope grew — none flagged as changes.
Inconsistency Gallantt reduced its capacity expansion target from 1.3 MT (May 2026) to 1.23 MT (July 2026) and its captive mine count from four to three, while increasing solar capacity from 78 MW to 85 MW without explaining any of the changes.Gallantt's operations are steady, but the shifting capacity and mine targets make the guidance harder to trust.
-
Dachepalli Publisher cut FY27 revenue guidance without explanation
Revenue guidance fell to ₹130-150 crore from ₹160-165 crore in two months; Pelican e-commerce projection also reduced.
Inconsistency Management lowered FY27 revenue guidance from ₹160-165 crore (May) to ₹130-150 crore (July) with no explanation. Pelican e-commerce projection was cut from ₹60 crore to about ₹39 crore implied. Printing capacity threshold rose from ₹250 crore to ₹300 crore without citing new investments.Dachepalli's revenue guidance flip is a credibility test; the growth narrative still works, but the numbers keep moving.
-
Fabtech's profit surge masks guidance cuts and acquisition delays
Q1 EBITDA turns positive on Saudi and Africa mix, but FY27 growth target has been steadily lowered from 30% to 20-25% and the European acquisition is pushed to year-end without explanation.
Inconsistency FY27 growth guidance was cut in successive calls: Feb 2026 targeted 30%, Apr 2026 came down to ~25%, Jul 2026 settled at 20-25%. The European acquisition timeline also slipped from Q1 to end-FY27. Management did not explain either change.Fabtech's profit surge is real, but the guidance game is undermining it.
-
Supreme Industries' agri demand reversal: strong Q1 guidance gave way to destocking shock
Management had guided for strong agri demand in Q1; now says farmers were hesitant due to polymer price drops. Volume fell 14% but profit rose 25% on mix.
Inconsistency In Jan and Apr 2026, management said agricultural demand had started in full force or would come through strongly during Q1. In Jul 2026, management said agri growth had been affected during April and June and that the next demand would start only in mid-September, blaming polymer price volatility that the prior call had already acknowledged.Supreme's agri demand reversal is a credibility gap. Full-year guidance survives, but the path to delivery now carries more risk.
-
Fairchem Organics cut its FY27 utilization target and can't say the margin improvement is real
Revenue rose 34% but volume was flat; management now expects 70-75% capacity utilization, down from 80%, and admits margin sustainability depends on China
Inconsistency Management lowered the FY27 capacity utilization exit target from 80% to 70-75% without explanation, while also walking back confidence in margin sustainability — from expecting improvement to saying it cannot confirm if the current 10.1% margin will hold. Paint concentration was disclosed at 40% of revenue, contradicting earlier statements of no major concentration.Fairchem's margin is a function of Chinese behaviour, not its own. Until that changes, the guidance can't be taken at face value.
-
Aurionpro withdrew FY27 guidance after promising 'strong' year
Q1 EBITDA margin of 17% and cautious tone contrast with May's confidence. R&D costs also revised higher to 10.5-11%.
Inconsistency In May 2026 management said it was not planning a significant margin dip and was confident for a strong FY27. In July 2026, Q1 EBITDA margin was 17%, guidance was withdrawn, and management described itself as only cautiously optimistic. R&D spending range was raised from 9-10% to 10.5-11% without explanation.Aurionpro's long-term data center story is intact, but the sudden withdrawal of FY27 guidance and R&D cost revision weaken short-term credibility.
-
Indoco cut its debt repayment plan by 22% without explanation
Management said in May it would repay ₹140 cr this year; in July it said ₹110 cr. Meanwhile, the USFDA audit remains unresolved and the rationale for the ophthalmic divestment has shifted.
Inconsistency Indoco reduced its near-term debt repayment target from ₹140 cr to ₹110 cr (down 22%) without explaining the change. Also, management denied in May that the ophthalmology divestment was for liquidity, but in July acknowledged proceeds went toward debt repayment.Margin surprise is real, but a 22% cut in the debt plan without a reason undermines the narrative.
-
TTK Prestige strong quarter, but two data points contradict prior guidance
Exclusive-store share jumped from 12-15% to 18-20% without explanation; raw-material inflation revised down from 10% to 8% despite continued cost pressure talk.
Inconsistency Exclusive-store contribution rose to 18-20% from 12-15% in prior calls without explanation. Raw-material inflation was revised down from ~10% to ~8% despite management describing continued commodity pressure.Strong volume growth, but unexplained metric shifts undercut an otherwise clean narrative.
-
Varun Beverages' Twizza deal dilutes margins, contradicting earlier 'accretive' guidance
Consolidated EBITDA margin fell 76 bps as Twizza's lower margins dragged, despite India margin expansion of 38 bps. Management had called Twizza 'margin accretive' in February.
Inconsistency In February 2026, management said Twizza would be margin accretive. In July 2026, it said Twizza operates at lower margins and caused a 76 bps EBITDA margin decline. No explanation for the gap was given.Varun Beverages' Twizza acquisition delivered volume but not the promised margin, and the unexplained gap raises questions about guidance reliability.
-
Tejas Networks' BSNL order scope jumps 44% from 18,000 to 26,000 sites without explanation
Patents granted also drop from 370 to 300 despite rising filings, raising credibility questions on two key metrics in a single quarter.
Inconsistency Tejas Networks described the pending BSNL 4G expansion order as covering 26,000 sites in July 2026, up from 18,000 sites stated in January 2026. Management confirmed it is the same order but offered no explanation for the scope change. Separately, cumulative granted patents declined from 370 to 300 while total filings rose from 613 to 722, again without explanation.Tejas needs to clean up its own numbers before investors can trust its guidance on the BSNL order.
-
HUDCO's NPA resolution pulled to FY27 – but project cycle stretched to 5 years
Chairman Sanjaya Kulshreshtha now expects to resolve most legacy NPAs this fiscal year, six months after saying 'by end of next financial year'. Meanwhile, the MOU pipeline's disbursement timeline extended from 3-4 years to 5 years.
Inconsistency In February 2026, management expected most NPAs resolved by end of next financial year. In July 2026, it said resolution within current FY. Separately, the project disbursement cycle was said to be 3-4 years in February, but now 'another five years'. No explanation for either shift.HUDCO's guidance flexibility is a feature, but the credibility gap from a single call is a risk that needs closing.
-
Aeroflex's record quarter masks a capacity credibility gap
Revenue surged 72% to ₹146 cr but management changed the flexible hose capacity baseline from 17.5m to 7.5m meters and delayed skid expansion by four months without explanation.
Inconsistency Flexible hose capacity baseline: In January 2026 management said installed capacity was 17.5 million meters per annum, with 2.5 million meters to be added by Q2 FY27. In July 2026 they said current production is 7.5 million meters and the path to 20 million meters would complete in Q3 FY27 — a materially different baseline and timeline with no reconciliation. Skid capacity expansion: The 15,000-unit target was committed for June 2026 but is now delayed to October-November 2026 due to supplier issues, with no quantified recovery plan.A record quarter is not the same as a reliable guidance track. Aeroflex's capacity flip-flop demands a proper explanation.
-
Digitide Solutions drops FY27 revenue growth target, prioritises margin improvement
CEO Sameer Ahuja tells investors to measure the company on profitability, not revenue, as Q1 margin trough confirms a deliberate portfolio reset.
Inconsistency In prior calls (Jan and May 2026), Digitide management expressed confidence in double-digit FY27 revenue growth. In the Jul 2026 call, when asked directly, CEO Sameer Ahuja redirected to profitability and did not restate the revenue target. The company also doubled its FY27 margin improvement target from 100bps to 200bps without providing a bridge.Digitide's profitability reset is overdue but the strategy shift needs consistent execution and communication to rebuild trust.
-
Nelcast accelerates new-product ramp, dials back European target
CEO P Deepak says new programs will reach mature volume by Q4 FY27, a year earlier than Feb guidance, while Europe orders remain 'small foothold' versus prior 30% export target.
Inconsistency In Feb 2026, management said new products would commercialize from FY27 with a ramp into FY28. In Jul 2026, it said these businesses would reach mature volume by Q4 FY27, pulling the timeline forward. Separately, the Oct 2025 expectation that Europe would become 30% of exports was replaced by a description of European wins as only a 'small foothold', with customers slower to move than anticipated.Nelcast's transformation story is credible, but its guidance hinges on delivery; investors should watch Q2 ramp and price pass-through.
-
Usha Martin cuts LRPC target, recasts capex without explanation
Q1 revenue rose 16.4% and EBITDA margin hit 20.1%, but management slashed its plasticated LRPC volume target by a third and recast its two-year capex plan into a single-year spend — shifts it did not explain.
Inconsistency In April 2026, management guided for FY27 plasticated LRPC volumes of 5,000-6,000 tons; in July the target was cut to 3,500-4,000 tons, citing delayed approval paperwork. Separately, the April call described ~₹300 crore as total capex over two years; the July call guided ₹250-300 crore for FY27 alone, implying a materially higher annual pace without explanation.Usha Martin's Q1 numbers are strong, but two unexplained guidance shifts make the forward view harder to trust.
-
CCL defers expansion, EBITDA confidence flips without explanation
Q1 volume grew 20%, net debt fell to ₹963 cr, but management dropped a planned small-pack expansion and raised EBITDA per kg guidance — both reversals from prior calls.
Inconsistency In February 2026, CCL said it was running out of small-pack capacity and would expand 'in the near future'. In July 2026, it said no capex is planned for two years. Separately, management shifted from 'EBITDA per kilo could soften' in May 2026 to 'sacrosanct throughout the year' in July, without a clear reason beyond Q1 results.Strong Q1, but two unexplained reversals make CCL's medium-term strategy harder to trust.
-
Happiest Minds’ guidance shift and banking deal delay test credibility
Q1 revenue ₹629 cr, up 4% QoQ, but management now says FY27 12.5% growth target depends on back-half deal conversions, a reversal from earlier first-half visibility.
Inconsistency In May 2026, management said delayed Arttha license deals were expected to close in Q1FY27. In July 2026, the update on the top banking deal said another part was still pending and expected to close in Q2 – a one-quarter delay without explanation. Separately, management shifted from stress-testing first-half performance to saying the FY27 12.5% growth target depends on converting large deals in Q3 and Q4, a meaningful shift in execution dependence.Happiest Minds’ AI story is intact, but guidance credibility is now tethered to back-half execution. Q2 will be the first test.
-
Tata Chemicals says it will keep exporting to Southeast Asia after telling investors it had stopped
After two quarters of promising to exit unremunerative SE Asia shipments, management now says break-even volumes will continue all year with no explanation for the change in policy.
Inconsistency In February and May 2026, management said it had stopped unremunerative Southeast Asia shipments except for one pre-existing contract. In July 2026, management said those exports are at break-even and will likely continue through the year, a clear reversal of stated policy without explanation.Tata Chemicals' standalone business is holding up, but a flip-flop on export policy raises questions about the de-commodification strategy's credibility.
-
Northern ARC softens FY27 ROA target to 'closer to 3%' from 3.2% without explanation
The NBFC posts strong Q1 with PAT up 41%, D2C AUM crossing ₹10,000 crore, but management's guidance changes on ROA, credit cost and MFI protection disclosure raise credibility questions.
Inconsistency January 2026: management targeted ROA of 3.2% for FY27. July 2026: target softened to 'closer to 3%'. Also, credit cost guidance revised down to 2.6-2.7% from 2.7-2.8% in May, and MFI coverage changed from 84% under CGFMU to ~94% under CGTMSE without reconciliation.Northern Arc's numbers are good; its guidance credibility is softer than its ROA target.
-
C2C Advanced Systems gave two different receivables numbers on the same call
CEO said ₹15 cr would be received by July 31, but later claimed over ₹25 cr already realized since March 31 — no reconciliation offered.
Inconsistency Within the July 2026 call, management first said at least ₹15 cr would be received by July 31, then later stated over ₹25 cr had been realized since March 31. The two figures were not reconciled, creating uncertainty about collection progress.C2C's collection recovery is the only metric that matters. The CEO's own numbers don't yet add up.
-
Senores slashes branded generics target after promising ₹80-100 cr. No reconciliation given.
India domestic revenue guided to ₹50-60 cr for FY27, down from earlier projections of ₹80-100 cr, as management pivots to profitability without bridging the gap.
Inconsistency In Nov 2025 and Jan 2026, Senores management projected branded generics revenue of ₹80-100 cr and ₹80-plus cr respectively for the next year. In Jul 2026, the India domestic business target was cut to ₹50-60 cr, attributed to a profitability-first strategy, but the prior targets were not reconciled.Senores' branded generics guidance flip is a dissonance the strong pipeline doesn't resolve.
-
Epigral reversed its epoxy strategy within six months
The board approved a 125,000-ton epoxy resin plant after management said in January it had no plan to enter the business, leaving the pivot unexplained.
Inconsistency Epigral's management told investors in January it had no plan to enter epoxy. In July it announced board approval for a 125,000-ton epoxy resin plant with no explanation for the pivot. The company also reversed its view on India's caustic soda trade balance, from net exporter to net importer, without reconciling the change.Epigral's growth story is ambitious, but the strategy whiplash makes the numbers harder to trust. Credibility first.
-
TMB's capital adequacy dropped 11.57 ppt without explanation; guidance raised elsewhere
Capital adequacy fell to 22.16% from 33.73% in three months, yet management boosted FY27 growth targets and said nothing about the gap. Gold loan stress cushion also shrank.
Inconsistency Multiple material inconsistencies surface across capital, provisioning and gold risk. Capital adequacy dropped 11.57 ppt from 33.73% (Apr'26) to 22.16% (Jul'26) with no reconciliation. Shareholders' funds reversed from above ₹10,000 cr to ₹3,125 cr. ECL provision requirement rose to ₹324 cr from ₹279 cr, yet management shifted from 'can provide immediately' to 'no immediate pressure'. Gold price stress cushion fell from 25% to 20% without explanation.TMB delivered a strong quarter, but unreconciled capital and shareholder figures make the financial story incomplete. Credibility matters more than growth here.
-
Mold-tek's lube guidance flips: from stabilised to 17% drop
EBITDA per kg hit a record ₹46.7 in Q1, but a fresh lube disruption, unexplained capex increase and a repurposed plant raise doubts about forecast reliability.
Inconsistency In May 2026, management said lube volumes had stabilised after losing PSU business and expected to sustain current levels. In July, they reported a 17% decline due to base oil unavailability at private customers. Separately, FY27 capex guidance rose from ₹80-85cr to ₹90cr without explanation, and the new plant's purpose shifted from pharma to medical devices.Mold-tek's lube turnabout and unexplained capex shift undermine the comfort its record EBITDA per kg would otherwise provide.
-
RR Kabel moved its FY27 margin target above 9.5%—after guiding exactly 9.5% in April
Q1 revenue jumped 54% to ₹3,168 cr and EBITDA doubled, but the real news is a margin guidance revision the company hasn't explicitly acknowledged.
Inconsistency In April 2026, management guided to a 9.5% wires-and-cables margin for FY27. In July 2026, management said it intends to touch double-digit margins this year, implying an upward revision to at least 10%. The change was not reconciled.RR Kabel's numbers are impressive. Its undisclosed margin revision is not. The difference matters.
-
Share India's guidance targets shifted without explanation
Management raised PMS AUM target by 25%, recast MTF horizon and accelerated branch breakeven assumptions — none were explained on the call.
Inconsistency Share India management raised the PMS AUM target from ₹200 cr to ₹250 cr, changed the MTF target from ₹650 cr in FY27 to ₹1,000 cr over two years, and shortened the branch MTF breakeven requirement from 10-15 cr in a year to 15 cr in 8 months, all without explaining the revisions.Share India's guidance shifts need a bridge. Without one, credibility is on the line.
-
Zen Technologies' order-book guidance slid from Rs 3,000 cr to Rs 2,500 cr in one quarter
Management said in May it was reasonable to expect an order book of Rs 3,000 cr. In July it dropped to 'around 2,500 crores' with no explanation for the change.
Inconsistency In February 2026, Zen Technologies guided for an order book of Rs 2,500-3,000 cr by FY27-end. By May 2026, management said touching Rs 3,000 cr was 'reasonable'. In July 2026, the target was narrowed to 'around 2,500 crores', a reduction of roughly Rs 500 cr from the upper end, with no explanation for the change in timing, conversion, or execution assumptions.Zen Technologies' guidance lost Rs 500 cr in one quarter. The street needs a bridge.
-
Bharat Electronics' QRSAM order slips to September, third timeline shift
Order book steady at ₹72,258 cr, but two major program timetables — QRSAM and AMCA — have slipped materially from prior guidance.
Inconsistency In October 2025 and January 2026, BEL management expressed high confidence in receiving the QRSAM order before March 2026. In the July 2026 call, the expected receipt moved to September 2026, attributed to procedural delays. This is the third timeline shift and leaves timing risk unresolved.BEL's Q1 execution is strong, but the third QRSAM delay tests guidance credibility. The September deadline is now the benchmark.
-
Emerald Finance contradicted its own Q4 Gold Loan and EWA numbers without explanation
Gold Loan distribution volume was ₹275 cr in the latest call, down from ₹375 cr reported in June. EWA average ticket nearly doubled to ₹46,000. Management did not bridge either gap.
Inconsistency Gold Loan distribution volume for Q4 was reported as ₹375 cr in the June 2026 call but as ₹275 cr in the July 2026 call — a 36% discrepancy. EWA average ticket size jumped from ₹25,000 to ₹46,000 without explanation of product mix or metric changes. Management did not reconcile either difference.Emerald Finance's operational story is intact. Its data story needs repair before investors can fully trust the numbers.
-
Ganesh Housing's MillionMinds leasing slipped to 43% with rentals delayed to Q4 FY27
Management pushed leasing targets twice, with rentals now starting Q4 FY27 and long-term development potential cut from 18 mn to 15 mn sq ft.
Inconsistency MillionMinds leasing milestones slipped: In Feb 2026 management expected 100% leasing by March; in Jun 2026 rentals were expected from Q3; Jul 2026 showed only 43% LOIs, rentals moved to Q4 FY27. Development potential reduced from 18 mn to 15 mn sq ft without explanation.Ganesh Housing's leasing narrative has slipped twice. The annuity transition is real, but the timing keeps moving.
-
Canara Bank triples digital spend target, raises deposit growth guidance
Management's annual digital investment estimate jumped from ₹1,000 cr to over ₹3,000 cr without explanation. Deposit growth guidance also lifted from 9-10% to 10-12%.
Inconsistency In January 2026, management said annual digital spending was around ₹1,000 cr. In July 2026, it earmarked over ₹3,000 cr – a threefold increase – without explaining the scope change or new programs. Also, deposit growth guidance was raised from 9-10% (May 2026) to 10-12% (July 2026) without a clear reason.Strong Q1 numbers, but three unexplained guidance tweaks make the forward path harder to trust.
-
SMC Global's insurance agent count jumped tenfold in one quarter with no explanation
Insurance agents surged from 16,610 to 1,67,404 in three months, while POS agents were reported separately at 16,747. This makes distribution metrics unreliable for growth assumptions.
Inconsistency Insurance agents rose from 16,610 in May 2026 to 1,67,404 in July 2026, a tenfold jump, without any definition change or explanation. Separately, the same July call reported a POS network of 16,747, making the distribution figures internally inconsistent.SMC Global's insurance metrics need a fix before its distribution story is credible. The diversification holds promise, but credibility comes first.
-
V-Mart LimeRoad loss cut slows to 39% from 70% claim in May
Management said three months ago that losses had been cut 'almost 70%'. The latest quarter shows only 39% year-on-year reduction — the gap of about 30 percentage points is unexplained.
Inconsistency In May 2026 management claimed LimeRoad losses had been cut 'almost 70%' versus the prior year. In July 2026 they reported a 39% year-over-year reduction for Q1 FY27. The apparent 30-point gap between the two figures was not reconciled in the latest call.V-Mart's core business is improving, but the LimeRoad loss math doesn't add up. Credibility is on the line.
-
Neogen cuts battery revenue guidance by 25-40% without explanation
FY27 battery target drops to ₹300 cr from ₹400-500 cr, while Dahej commissioning slips and Morita equity timing extends.
Inconsistency FY27 battery revenue guidance was cut to ₹300 cr from the previously indicated ₹400-500 cr, with no explanation for the gap. Separately, Dahej commercial production slipped from June 2026 (Q1) to Q2 FY27, and Morita's $20 mn equity contribution was delayed from H1 to Q2-Q3 FY27.Neogen's battery story looks promising, but sliding guidance and deadlines make it harder to underwrite.
-
LMW's ATC order book triples without explanation, margin guidance reversed
ATC backlog jumps from ₹360 cr over 18 months to ₹1,000 cr over 3-3.5 years; MTD margin recovery timeline withdrawn. Diversification remains exploratory.
Inconsistency ATC order book jumped from ₹360 cr over 18 months (May & Feb 2026) to ₹1,000 cr over 3-3.5 years (July 2026) without reconciliation. MTD margin outlook reversed from 'expected to continue' to 'cannot put a timeline' on recovery.LMW's ATC order book grew, but at the cost of clarity. MTD margins are a wait-and-watch. Pick your risk.
-
Vedant Fashions changes store closure mix, contradicts earlier guidance
In Q1 FY27, the company deliberately closed larger stores, reversing its earlier strategy of shutting smaller ones. GST normalization timing also shifted.
Inconsistency Store closure mix: In Feb and May 2026, management said it was closing smaller stores (≤1,000 sq ft). In Jul 2026, it said it deliberately targeted larger stores in Q1. GST impact: In May 2026, management said normalization would largely happen from FY27. In Jul 2026, it said Q1 FY27 is not in the base and full impact starts from Q3.Two strategic pivots in one call make the steady numbers feel less steady.
-
Huhtamaki delayed solar power timeline, revised growth story
Management pushed renewable energy project to Q3 without explanation, and changed its explanation for Q2's 23% sales growth: from normal demand to crisis-driven inventory buildup expected to normalize.
Inconsistency Renewable energy project delayed from Q2 to Q3 without explanation. Also, management changed its characterization of Q2 growth: in May it said crisis-related volume was stabilizing and underlying demand normal; in July it attributed part of the growth to customer inventory buildup from the Middle East crisis, some of which will reverse.Huhtamaki's renewable delay and growth-quality revision raise questions about visibility and guidance reliability.
-
Monolithisch India says SGB is 50% of revenue. Its own volume data says less.
The company claims SGB Limited drove half of Q1 revenue, but disclosed volume and pricing imply a materially lower contribution. The gap is unexplained.
Inconsistency Management states SGB contributed 50% of revenue, but volume of 20,000 to 20,500 MT out of 52,000 total, at disclosed pricing, implies roughly 38 to 39% of volume and likely less than 50% of revenue. No reconciliation was provided.Monolithisch India's SGB premiumization story is impressive, but the numbers don't add up, and that erodes trust in guidance.
-
Tanfac's capex plan tripled. Funding mix changed. No reconciliation offered.
Management increased total capex guidance from ₹500-700 cr to ₹1,500-1,700 cr over four years, and altered the R-32 funding mix from ₹300 cr QIP+debt to ₹250 cr QIP plus preferential issue, without bridging either discrepancy.
Inconsistency CapEx framework changed materially: In May 2026, management guided for ₹500-700 cr over 3-5 years after R-32. In July 2026, total capex was pegged at ₹1,500-1,700 cr over 4 years, without reconciling whether the prior range was included. R-32 funding mix also changed: In May, ₹400 cr was planned (₹100 cr from promoters, ₹300 cr via QIP and term debt). In July, ₹250 cr QIP was completed and a ₹100 cr preferential (₹61 cr from promoters) proposed, with no explanation for the different mix.Tanfac's capital plan has tripled and its funding story has changed. Without a bridge, guidance is harder to trust.
-
Assoc Alcohols RTD timeline slips, can changes without explanation
Two months ago management said RTD label approvals would come in 1-1.5 months. Now they say registration is underway across 8 states. And the can shrank and got cheaper — 330 ml at ₹120 vs 300 ml at ₹130.
Inconsistency In May 2026 Assoc Alcohols expected RTD label registrations within 1-1.5 months. In July 2026 they said registration was 'underway' for 8 states without addressing the delay. Separately, the RTD can went from 300 ml at ₹130 to 330 ml at ₹120, changing implied unit economics without explanation.Strong proprietary growth meets an RTD credibility gap. The timeline slip and pack change need a bridge before the guidance can be taken at face value.
-
GRP raised volume guidance for reclaim and plastic recycling without explaining the bridge
Reclaim rubber volume target moved from mid-teens to 'close to 20%' and plastic recycling from mid-to-high teens to 'over 20%' in FY27, a material upward revision without quantified support.
Inconsistency In the Feb 2026 call, management guided reclaim rubber volume growth in the mid-teens and plastic recycling growth in the mid-teens to high-teens for FY27. In the Jul 2026 call, both targets were revised upward: reclaim to close to 20% and plastic to over 20%, without a quantified bridge or reconciliation.GRP's guidance upgrade is good news, but the missing bridge makes it harder to underwrite. Consistency counts.
-
Canarys Automations claims ₹370 cr recurring revenue, but total income is ₹199.7 cr
Management described ₹370 crore as recurring revenue consumed across multi-year contracts, but FY26 consolidated total income was just ₹199.7 crore. The gap suggests the ₹370 crore includes forward order book or unearned revenue.
Inconsistency In the same Jul 2026 call, management reported FY26 consolidated total income of ₹199.7 crore but later described approximately ₹370 crore as current recurring revenue, consumed across projects with one- to three-year terms. The ₹370 crore figure appears to include order-book value rather than recognized revenue, creating a definitional conflict.Canarys' revenue math adds up only if you define recurring as order book. That is not how the market reads it.
-
Prudent's non-GST AUM mix dropped from >50% to 40%. The flip was not explained.
Partner additions surged to 600/month, and PAT rose 44.4%, but management left investors to reconcile a 10-percentage-point shift in the AUM mix that underpins margin guidance.
Inconsistency In January 2026 management said more than 50% of AUM came from non-GST partners. In July 2026 that figure was almost 40%. The change was not reconciled on the call.Prudent's numbers are strong; its credibility on margin input is not. A 10-point mix gap needs a why.
-
Shakti Pumps postpones two capacity milestones, Kusum launch slips
Four months ago, the 0.5 GW module was due in Q1 FY27. Now it's September. The 2.2 GW plant has moved again. PM Kusum 2.0 is still with the PMO.
Inconsistency The 0.5 GW module facility was targeted for Q1 FY27 in both the February and May 2026 calls; the July 2026 call pushed completion to September 2026 without explanation. The 2.2 GW solar cell facility, previously guided for April 2027 (Feb) and March 2028 (May), is now expected in September 2027. PM Kusum 2.0 rollout, expected by end-Q1 FY27 in May, is now described as 'waiting for clearance at the PMO' with no firm date.Strong demand today, but repeated timeline slippages make the margin recovery story harder to believe.
-
3I Infotech's RailTel project reversal matches a product strategy shift
A project management said would be 'back onstream in weeks' is now in arbitration that could take years. The product pivot adds to the credibility gap.
Inconsistency In May 2025, management said a partner would make the RailTel platform operational within weeks. In Jul 2026, the project is in arbitration with RailTel wanting another party, and 'the case may take years to conclude'. Also, management said in May 2025 it had 'no intentions of adding any products', yet in Jul 2026 described expanding its Nuere proprietary platform portfolio without explanation.3I Infotech's execution is improving, but two unexplained strategy reversals make its long-term guidance hard to trust.
-
Welspun Corp reverses India demand outlook, pivots to exports
Record EBITDA of ₹756 cr and ₹25,750 cr order book mask a material deterioration in domestic water demand that management did not flag until now.
Inconsistency In February and May 2026, management described Jal Jeevan Mission funding as recovering with traction and a 'complete resurgence'. In July 2026, it said funding constraints and overcapacity persist, no sudden rebound is expected, and the company has shifted focus mostly to exports.Record earnings hide a domestic demand reversal that management did not warn the market about. Execution is strong; trust is now the question.
-
Concor doubled its FY27 growth guidance after one quarter. It did not say how.
Growth target raised from 9.5% to 18% – an 89% increase – with DFC, tank containers and a prospective contract cited but not quantified.
Inconsistency In May 2026 Concor's management guided to 9.5% full-year FY27 growth. In July 2026, after one quarter, it raised that to 18% total growth – a near-doubling of the target. Chairman Sanjay Swarup cited DFC connectivity, tank containers and a prospective domestic contract, but did not quantify how these developments support the step-up, which is material to the investment model.Concor's revised guidance is a bold call that needs a bridge. Without one, the upgrade is as much a risk as a catalyst.
-
Orient Green Power's promoter pledge slips, AP risk worsens
Growth ambition stalled as capital raising remains unresolved, while management missed a Feb deadline on promoter pledge and disclosed a disputed AP receivable provision.
Inconsistency In Feb 2026, management targeted releasing the promoter pledge 'before middle of next month'. By Jul 2026, the shares remained pledged and the target shifted to 'end of the financial year', with final loan due date Sep 2027, a material timing revision not reconciled. Separately, AP collections were described as 'quite smooth' in May 2026, but Jul 2026 revealed Rs 6.5 cr provision against disputed interest of Rs 20 cr, a clear deterioration in the credit narrative.Orient Green Power's ambitions are real, but its capital and credibility are running behind schedule.
-
KFin cut FY27 revenue guidance from 23-24% to 18-20%, reversed stance on Philippines contract
In three months, the company reduced its top-line outlook by 4 percentage points, accelerated Ascent margin timing, and said a contract it previously called won had not been awarded.
Inconsistency Management cut FY27 revenue guidance from 23-24% to 18-20% and international growth outlook from over 60% to 30% without reconciling the changes. It also accelerated Ascent's double-digit margin timeline from a 'couple of years' to 'within 12 months'. Most critically, the Philippines contract, described as 'successfully completed' in April, was revealed in July as not yet awarded.KFin's diversification is real, but its forecasting credibility just took a hit. Fix that first.
-
Kross missed its own tipping-jack target by a wide margin. Axle-shaft supply timing also ambiguous.
Q1 tipping jack production of ~200 kits vs 300-unit target set in May; axle shaft facility by September but no commitment on supply readiness.
Inconsistency Tipping jack ramp materially below prior targets: In January and May 2026, management guided for 750 and 300 units respectively in Q1 FY27, but actual production was around 200 kits. No reconciliation was given. Additionally, the May 2026 commitment to supply rear axle shafts by September 2026 was softened to only commissioning by September, leaving supply timing unresolved.Kross is growing but its own guidance on tipping jacks keeps falling short. Trust the ramp only when validated.
-
Five Star Business's ROA target just fell. So did its guidance credibility.
Steady-state ROA guidance dropped from 8-8.25% to 6-6.5% in the same quarter that management also raised credit cost ceilings and reversed its stance on technical write-offs. The common thread: an unexplained strategy pivot.
Inconsistency In April 2026 management guided steady-state ROA of 8-8.25%. In July 2026 it cut the target to 6-6.5%, citing compression from higher borrowing costs. Simultaneously, management reversed its long-held opposition to technical write-offs, now planning 225-250 cr in FY27 write-offs versus 160-165 cr in FY26, with no explanation for the policy change.Five Star's numbers are getting better, but its guidance credibility is getting worse. That tension is the story.
-
Dodla Dairy lowers Africa revenue outlook, cuts FY27 margin guidance
Africa revenue now seen at ~10% of total vs 15-18% guided two months ago. EBITDA margin range reduced to 7-8% from 8-9%.
Inconsistency Africa revenue contribution outlook reduced from 15-18% by FY28 in May 2026 to ~10% in July 2026. FY27 EBITDA margin guidance lowered from 8-9% to 7-8%. Management attributed margin pressure to procurement costs and delayed price pass-through but did not reconcile the change.Dodla's record quarter is overshadowed by two guidance cuts and no explanation for the Africa reversal. Margin recovery needs to materialize soon.
-
IDFC First Bank's CEO admits cost-to-income timeline was wrong even as profits cross 1% ROA
V Vaidyanathan reversed his confident April 2026 guidance on liability drag, saying he got it wrong. Q1 PAT hit ₹1,075 cr, but one-off gains and a rising cost base cloud the narrative.
Inconsistency In the April 2026 call, CEO V Vaidyanathan said liability drag declining to zero was 'playing out exactly as planned'. In the July 2026 call, he admitted: 'I admit that in the first round, I got it wrong because I thought we would fix it in five years, and we are still dealing with it in the seventh year.' The earlier confident timeline was reversed without reconciling the factors.IDFC First Bank crossed 1% ROA, but the CEO's cost-to-income reset makes the next leg about cost-control credibility, not just credit healing.
-
Jindal Steel's captive iron ore mix slipped without explanation
Captive iron ore fell from 40% to 28% quarter-on-quarter, a swing management did not explain. The value-added push and Angul ramp-up are real, but the raw material story has a hole.
Inconsistency In May 2026 management said the captive iron ore mix was 40%. In July 2026 it reported 28%, a 12 percentage-point decline. The latest call does not explain the drop or whether the denominator changed, while only guiding to a 40% exit rate by year-end.Jindal Steel is executing well on value-add and capex discipline, but the unexplained iron ore swing undermines trust in its integration guidance.
-
Onesource Specialty pivots on DDC MSAs, accelerates soft gel timeline
Q1 revenue up 37% to ₹4,490 mn, but management's strategy reversal and shortened capacity fill raise guidance credibility questions.
Inconsistency In January 2026, management said it prioritized commercial sales and chose not to accept new DDC MSAs. In July 2026, it cited new MSA contracts as a revenue driver without explaining the pivot. Separately, the soft gel capacity fill timeline shortened from ~2 years to 12-15 months with no identified reason.Onesource's capacity story is promising, but unexplained strategy pivots and timeline accelerations demand clarity before guidance can be fully underwritten.
-
Bank of India lowered ECLGS 5.0 target by 20%+ unexplained
Profit surged 36% to ₹3,068 cr but management cut its ECLGS 5.0 funding estimate from 10-12 thousand cr to around 8,000 cr without explanation, raising questions about guidance credibility.
Inconsistency In May 2026 management expected to fund around 10-12 thousand crores under ECLGS 5.0. In July 2026 it said sanctions and disbursements would be around 8,000 crores, a reduction of at least 20% from the prior low end, without explaining whether the change reflected weaker demand, eligibility constraints, or a different measurement basis.BOI's profit surge is real, but the unexplained 20%+ cut in ECLGS 5.0 target chips away at guidance credibility.
-
Tata Consumer's GTM rollout was 100% complete in May. In July it wasn't.
Growth businesses surged 47% to Rs 1,300 cr, but a second reversal on go-to-market implementation raises questions about management's execution guidance.
Inconsistency In May 2026 management said the national go-to-market rollout for Capital Foods and Organic India was finished. In July 2026 it said the system was 'not fully fleshed out yet' because finding distributors takes time. No explanation was given for the reversal.Good quarter, but the GTM reversal is a pattern: management's promises are worth less than its results.
-
CreditAccess Grameen changes its story on mortgage profitability
In May 2026 management called mortgage the only unprofitable product. In July it said all products except two-wheelers are profitable, then added mortgage needs ₹1,000 crore more to break even including HO costs.
Inconsistency In May 2026 management stated mortgage was the only retail product not profitable at the product level. In July 2026 it said all products except two-wheeler loans are profitable, but then added mortgage still needs approximately ₹1,000 crores for full break-even including HO allocation costs. The shift in classification is material and unexplained.CreditAccess's numbers are strong, but the shifting story on mortgage profitability undermines confidence in its retail graduation narrative.
-
Bank of Baroda's ECL estimate tripled. No bridge given.
The bank said ECL impact would be 0.6-0.7% of CRAR, then 'well below', now 110 bps. Floating provision purpose also changed.
Inconsistency In Jan 2026 management estimated the ECL impact on CRAR at a maximum of 0.6 or 0.7. In May 2026 they said the final impact would be 'well below' that. In Jul 2026 they quantified it at 110 bps (roughly ₹12,000 cr), without reconciling why the final estimate exceeded the prior guidance. Separately, the floating provision balance rose from ₹1,500 cr (described as a general buffer) to ₹2,500 cr (now explicitly for ECL migration) without explanation.The settlement is done. The credibility gap is not. Until the ECL estimate is reconciled, trust in guidance is impaired.
-
SBI Life's GST timing flip and deferred annuity delay undermine guidance credibility
Management said GST impact would apply for a full year in April; now it's only 2.5 months. The deferred annuity launch missed its June target with no explanation.
Inconsistency GST Impact Timing Revised: In April 2026, management said the GST impact would apply for the full next financial year. In July 2026, it described only a residual impact for two and a half months of the current quarter, without reconciling the revised outlook. Deferred Annuity Launch Delayed: In April, management committed to launching by June; in July, launch was pushed to the next quarter without explanation.SBI Life's growth is real, but the GST flip and product delay make management's forward promises harder to trust.
-
Sapphire Foods reverses demand narrative; price hike contradicts prior pause
Management now says no material demand improvement — after attributing Q4 recovery to macro. KFC's 5% SSSG is execution-driven, not macro-led.
Inconsistency In April, management said the consumer environment had improved and attributed the recovery to both macro and company initiatives. In July, it said there had been no material improvement and credited only its own actions. Separately, management said no near-term price hike was expected unless raw material costs deteriorated, but then disclosed a further price increase in June.Sapphire's KFC recovery is real, but the inconsistency in management's macro narrative weakens trust in the broader story.
-
Asarfi Hospital's FY26 revenue target of ₹550 cr contradicts reported ₹173.5 cr
Management also reversed acquisition status from near-completion to early-stage, raising credibility concerns despite strong cancer-led growth.
Inconsistency 1) FY26 revenue target of ₹550 cr stated in July 2026 call conflicts with the ₹173.5 cr revenue reported for FY26 in May 2026. 2) The proposed 70-bed acquisition was described as 'almost settled' in May but as 'process has begun' in July, with no explanation for the change.Asarfi's cancer story is real, but the revenue contradictions make its guidance hard to trust. Credibility must come before scale.
-
CG Power's transformer capacity roadmap keeps shifting; Kavach approval delayed a year
Order book hit ₹17,333 cr, up 45%, but management has revised capacity targets three times in 18 months and repeated a 4-6 week RDSO approval timeline that was first given a year ago.
Inconsistency Transformer capacity roadmap changed across three calls: Jan 2025 guided to 85,000 MVA by FY27/28; Jul 2025 said existing plant would reach 40,000 MVA; Jul 2026 claimed 75,000 MVA already operational with another 45,000 MVA to come, implying ~120,000 MVA — no explanation for the revision. Kavach RDSO approval was expected 'in 4-6 weeks' in Jul 2025; a year later, same timeline with no explanation. Motor demand narrative reversed: 'market has further deteriorated' in Jul 2025 vs 'good traction' in Jul 2026, without clarifying if recovery or share gain.CG Power's order book is rocketing. Its guidance credibility is not. That gap is the risk.
-
Seshaasai Tech cuts IoT growth outlook, capex range; facility plan shifts
In two calls, management lowered FY27 IoT growth from 47%+ to 35-40%, cut capex from ₹160-200 cr to ₹140-160 cr, and swapped Nagpur for Nashik without explanation.
Inconsistency Seshaasai lowered its FY27 IoT growth outlook from 'upward of 47%' to a 35-40% range spanning FY26–FY28; slashed its FY27 capex plan from ₹160-200 cr to ₹140-160 cr; and replaced Nagpur with Nashik as a facility under construction, without addressing the prior locations. None of the changes were explicitly explained.Three guidance reversals in three months make Seshaasai's visibility look less clear than it claims.
-
Allied Blenders cuts ABD Maestro target, delays brand resets, lowers FTA margin view
Two months after saying Maestro would cross ₹100 cr, management now says it will double from ₹40 cr; packaging timelines for OC Blue and B7 pushed back; UK FTA benefit estimate trimmed by a third.
Inconsistency In May 2026, management said ABD Maestro would 'cross 100 crores' in annual revenue; in July it said FY26 revenue was ₹40 cr and FY27 would 'double' – implying ~₹80 cr. The UK FTA margin benefit was cut from 200 bps by FY28 to 130-140 bps. Brand reset packaging for OC Blue moved from Q2/Q1 FY27 to Q3, and B7 from Q1/Q2 to Q4, without explanation.Allied Blenders is delivering on volume but cutting guidance faster than it can explain. Credibility is the new risk.
-
Hindustan Zinc reports record EBITDA but zinc cost figure contradicts itself
Q1 zinc cost of production appears as both $1,851 and $851 per ton in same call; fertilizer commissioning delayed by at least a quarter.
Inconsistency Zinc cost figure discrepancy: Prepared remarks stated the lowest quarterly zinc cost at $1,851 per ton, while CFO later quoted $851 per ton for the same metric. Fertilizer plant commissioning: Previously guided for early Q2 FY27, now only phosphoric acid portion in Q2; fertilizer plant pushed to Q1 FY28 pending approvals.Record EBITDA masks a $1,000 cost gap and a broken fertilizer timeline. Credibility on numbers needs repair.
-
Greenply's debt and margin targets shift without explanation
Peak debt moved from 0.72x to 0.75x, and MDF ROCE target fell from 18-20% to 17-18%, with no rationale given for either revision.
Inconsistency In April 2026, management said debt-to-equity would peak at 0.70-0.72x and return to 0.5-0.6x; in July 2026, the peak moved to 0.75x and endpoint to 0.65-0.7x. Separately, the MDF ROCE target was lowered from 18-20% to 17-18% without any change in capex or market assumptions.Greenply's growth story is intact; its guidance credibility is not.
-
Acutaas accelerated CDMO peak to H2 FY27, delayed electrolyte Phase 2
Management pulled the CDMO revenue peak a full year earlier while slipping the electrolyte additive phase 2 by a quarter, with no explanation for either move.
Inconsistency Three inconsistencies emerged: (1) Electrolyte additive Phase 2 capex slipped from Q1 FY27 to Q2 FY27, yet management called it 'on schedule'. (2) CDMO peak revenue was pulled forward from FY28 to H2 FY27, an unexplained acceleration. (3) R&D molecule throughput was revised down from ~50 to 30-40 annually, without reconciliation.Acutaas is firing on multiple cylinders, but investors need clearer timelines and fewer unexplained shifts.
-
Data-center mix target jumps to 50%, no bridge given
Management raised the enterprise and data center revenue share guidance to 50% for FY27 from 30% in April without explaining how the 21% Q1 mix can reach that by year-end.
Inconsistency In April 2026 management guided to enterprise and data center at 30% of FY27 revenue. By July it said 50%, a 67% increase in the same period target. Q1 delivered 21% and the gap is not reconciled. Capex guidance also shifted from about ₹500 crore near term to ₹500 crore per year for three years without clarifying whether the old number was the first year piece or the total. The QIP went from an enabling resolution to a ₹1,500 crore executed raise in one quarter. EBITDA margin guidance rose from 20% to 23% yet reported EBITDA of ₹397 crore on revenue of ₹9,110 crore implies about 4.4%, far below either target.Sterlite Tech's numbers are strong; its guidance math is not. The strategy is working; the communication is not.
-
Mahindra Life pre-sales surged 106%. Its IC profit guidance just collapsed by 75%.
Management now expects ₹100-150 crore of IC PAT versus ₹550 crore guided three months ago, while historical GDV additions were quietly recast lower by 17%.
Inconsistency In April 2026 management guided for IC PAT of roughly ₹550 crore on ₹400-500 crore of revenue. In July 2026 it cut that to ₹100-150 crore on the same revenue range, a 75% reduction with no explanation. Separately, historical annual GDV additions were restated from ₹18,000 crore to ₹15,000 crore, and Thane's status regressed from 'work has truly started on the ground' to 'planning stages'.Mahindra Life's homes are selling. Its numbers are not.
-
Apar Industries' capacity utilization numbers shifted without explanation.
Conductor utilization fell from 90-95% to 80-90%, and oil utilization jumped from 65-70% to 80-90% in two months, but management offered no bridge.
Inconsistency In May 2026, management said conductor utilization was 90-95% and oil utilization 65-70%. In July 2026, they said all three divisions were at 80-90%, implying a decline in conductors and a jump in oil, without explaining methodology or capacity changes.Record profits, but a silent capacity calculation change erodes the credibility of Apar's disclosure.
-
PVR Inox slashes FY27 screen guidance to 90-100, EBITDA doubles
For the third consecutive call, management lowered its annual screen addition target from 150 to 90-100, while posting a blockbuster EBITDA of ₹230 cr and a net cash position of ₹80 cr.
Inconsistency In February 2026, management guided for about 150 screen additions in FY27. By May, that dropped to 120-odd. Now, in July, the target is 90-100 gross and nearly 80 net. The reason given, pending regulatory licenses, does not explain a 40% reduction in the full-year target.PVR Inox's EBITDA surge is real, but the repeated screen guidance cuts erode confidence in its growth narrative.
-
IIFL Capital's tax demand jumps to ₹124 cr after earlier saying no order existed
The tax demand more than doubled from ₹56 cr in May to ₹124 cr in July, with no entity split or explanation for the increase, as Fairfax control transaction awaits approvals.
Inconsistency In February 2026 management said there was no order or demand. By May 2026 it disclosed a ₹56 cr notice. In July 2026 the tax demand stood at ₹124 cr, covering the holding company and subsidiaries. Management did not reconcile the increase or explain why the entities involved broadened.IIFL Capital's tax disclosure gap undermines confidence even as Fairfax promises capital strength.
-
Coromandel's granulation project slips to Q4 with no explanation
A previously repeated timeline for the granulation expansion has been pushed back one quarter, while fertilizer EBITDA fell 3% and the company flagged subsidy and input-cost risks.
Inconsistency In February 2026, management said the granulation project would be commissioned in Q3 FY27; in May 2026, it guided for December. The July 2026 call moved the target to Q4 without explanation.Coromandel's diversification cushions the fertilizer blow, but the granulation delay and subsidy gap mean the margin recovery relies on execution and policy — both uncertain.
-
HEG delivered 29% EBITDA margin after guiding 20% two months ago
The margin beat is real, but management did not explain why the prior guidance was so far off or whether the improvement is sustainable.
Inconsistency In May 2026 management guided EBITDA margins of approximately 20% for the next two quarters. In July 2026 Q1 margin came in at 29% and management said it could maintain that level. No reconciliation was provided. Separately, February 2026 management said post-demerger Greentech debt would be negligible; now expects ~₹1,500 crore gross debt by March 2027.Whether the new margin level is sustainable or just a quarter of favorable mix is the open question.
-
Control Print's promises on packaging, V-Shapes and Track and Trace all slipped this quarter
The core coding business held steady, but management pushed packaging break-even to H1 FY28, admitted V-Shapes remain unreliable, and Track and Trace pilots failed to commercialize — three reversals in one call.
Inconsistency Packaging break-even timeline moved from FY27 Q3/Q4 to H1 FY28. V-Shapes execution confidence reversed from 'confident in taking more orders' to admitting customers find the system 'too difficult'. Track and Trace commercialization slipped from 'finalization stage' in Jan 2026 to still awaiting customer feedback in Jul 2026.Control Print's core coding is fine. Its new businesses are not — and the gap between promise and delivery is widening.
-
Motilal Oswal silently cut SIP run-rate; carry income numbers don't add up
Annuity mix hit 66% of group revenue, but two unreconciled carry figures (₹66 cr and ₹36 cr) and an unexplained guidance cut weaken the earnings quality story.
Inconsistency SIP run-rate reduced from ₹18,000 cr (Apr 2026) to ~₹16,000 cr (Jul 2026) without explanation. Also, carry income disclosed as ₹66 cr in one answer and ₹36 cr in another, with no reconciliation between the two figures.Motilal Oswal's annuity transition is real, but the silent guidance changes and unreconciled carry numbers erode the quality of the earnings narrative.
-
Shemaroo's Q1 call is labeled FY25. Its prior calls were FY26. No explanation.
The backward period label undermines period comparisons, reported results, and guidance. Debt repayment timing also shifted without a bridge.
Inconsistency The July 2026 call labels itself Q1 FY25, but the May 2026 call covered Q4 and FY26, and the January 2026 call covered Q3 and nine months of FY26. This backward period designation is unexplained. Separately, in January 2026 management said most debt repayment would come next year; in July 2026 they claimed a debt reduction plan for the current year without explaining the change.Shemaroo's operational progress is real, but the labeling error and unexplained debt pivot make guidance hard to underwrite.
-
Stylam delays plant again, trims margin forecast
Commercial production moves to September; sustainable margins cut to 19-20% plus from 22-24%. Credibility gap widens.
Inconsistency Plant commissioning delayed from mid-July to September, with cause shifting from environmental clearance to family matters. EBITDA margin outlook cut from 22-24% to 19-20% plus without explanation. Aica technology transfer timeline slipped from 2-3 months to indefinite.Stylam's execution narrative is fraying. The Q1 beat doesn't erase the delay, the margin cut, or the shifting explanations.
-
Capital Small Fin Bank calls 4.47% GNPA 'stable' after 76% QoQ spike
NIM improved to 4.2% but asset quality claims clash with a 1.93 ppt GNPA jump and a 40% agriculture ticket-size expansion, both unexplained.
Inconsistency In Apr 2026, management said GNPA was 2.54% and asset quality was 'well managed'. In Jul 2026, GNPA stood at 4.47% (a 76% increase) yet management again called asset quality 'stable' without explaining the deterioration. Separately, the agriculture lending ticket-size upper bound was raised from ₹25 lakh to ₹35 lakh (40% increase) with no reasoning, altering the risk profile.Capital Small Fin's NIM story is credible. Its asset quality story is not until the 76% GNPA spike gets a why.
-
IRB InvIT reversed its funding stance, plans ₹2,500 cr QIP after ruling out new equity in February
Six months ago management said IRB would not need additional equity for new projects. Now the InvIT is seeking a ₹2,500 crore QIP alongside debt, an unexplained pivot that raises questions about capital allocation credibility.
Inconsistency In February 2026, management said IRB would not need additional equity for new projects and that there would be no equity outflow from the listed company. In July 2026, the InvIT said it was seeking a QIP of approximately ₹2,500 crores alongside debt to fund acquisitions. The change was not reconciled.IRB InvIT's funding contradiction clouds an otherwise sturdy toll performance. The QIP pledge to protect payout will be tested by price.
-
Suryoday's ₹387 cr claim windfall comes with a timing contradiction
Management expected ₹450-550 cr in FY27 claims, but now says only ₹13-15 cr left this year and ₹135-150 cr more at an unspecified time.
Inconsistency In May 2026, management guided for ₹450-550 crore in FY27 guarantee claims, with most in H1. In July 2026, after receiving ₹387 crore, they said only ₹13-15 crore remains claimable this year, plus an additional ₹135-150 crore 'later' — without clarifying whether that falls within FY27.Suryoday's claim windfall is real, but the timing is fuzzy — and that matters for near-term earnings models.
-
Spandana cut FY27 AUM guidance by 7% without explanation
Two months after targeting a ₹6,500 cr AUM exit, management now expects 'slightly above ₹6,000 cr'; also lowered 90+ recovery outlook and changed LOS vendor identity.
Inconsistency In May 2026, management guided for FY27 exit AUM of ~₹6,500 crores. In July 2026, that target was cut to slightly above ₹6,000 crores — a ~7% reduction — without any discussion of what changed. Similarly, the 90+ recovery target was lowered from ₹20-25 crore a month to an average of ₹16-18 crore, with management saying ₹20 crore looks difficult.Spandana's operational turnaround is genuine, but the guidance gaps on AUM, recoveries and platform execution make the story harder to trust at current prices.
-
Mphasis DSO reversal and platform flip-flop cloud Tria launch momentum
Q1 FY27 revenue up 2.1% sequentially, but DSO deteriorated to 95 days from an adjusted 86 days, and NeoIP was replaced by Tria as the flagship platform without explanation.
Inconsistency In Jan 2026, Mphasis reported DSO of 91 days; by Apr 2026 it had improved to an adjusted ~86 days. In Jul 2026, DSO jumped to 95 days, a material reversal with only a vague promise of future improvement. Separately, NeoIP was the flagship platform in Jan and Apr 2026 calls; the Jul 2026 call replaced it with Tria without clarifying whether Tria is a rebrand, replacement, or integration.Strong bookings and Tria traction are offset by a DSO reversal and unexplained platform pivot, leaving the FY27 thesis dangling.
-
Fractal's TMT weakness story shifts from client issues to AI capex reallocation
In three months, the narrative flipped from contained client problems to a broad opex-to-capex shift, without reconciling the earlier guidance or explaining the delayed recovery.
Inconsistency In May 2026, management attributed TMT weakness to client-specific issues expected to resolve in 'the next few quarters.' In July 2026, it cited a broader shift from opex to AI capex, changing the risk from contained events to a sector-wide budget issue. The earlier timeline for the 60% outcome/output/license mix was also accelerated from 'two to three years' to 'the next few quarters' without explanation.Fractal's numbers are solid, but the shifting explanations on TMT, mix targets and associate losses create a new layer of execution risk.
-
Go Digit said it doesn't give guidance. Three months ago it gave a ₹1,000 cr premium projection.
The insurer's Q1 FY27 results show a deliberate pivot from growth to profitability, but a new contradiction between guidance policy and a prior quantified projection raises a credibility question.
Inconsistency In April 2026 management projected specialized commercial lines could generate ₹1,000 cr in premium within 3-5 years. In July 2026 it said 'we do not give guidance' and refused to offer any forward numbers. The two statements are directly inconsistent.Digit's profitability is a choice; its credibility is not guaranteed.
-
Thyrocare's specialty timeline stretched to 5 years from 3, without a why
In Q1 FY27, Thyrocare pushed its specialty diagnostic mix target to 3-5 years from a prior 3-year horizon, while core pathology revenue grew 26%.
Inconsistency In Jan 2026 and May 2026 calls, management said specialty mix would reach 15-20% in 3 years. In Jul 2026, the timeframe widened to 3-5 years with no explanation. Prior call (May 2026): 'I anticipate in 3 years reaching that level.' Latest call: '3 to 5 year timeframe.'Thyrocare's specialty expansion has a timeline problem, but the core business is strong enough to let it take the time.
-
Geojit says it's not hiring, then blames Q1 cost spike on salesforce expansion
Management told investors in April it was freezing field hiring; now employee costs are up ₹18 cr on salesforce, DIFC and tech additions, and productivity payback has stretched to 24 months.
Inconsistency In April 2026 management said it would not hire incremental field staff except to replace vacancies. In July it attributed Q1 employee-cost growth to salesforce expansion, DIFC recruitment and technology additions. Separately, the expected salesforce payback timeline was extended from 12-18 months to 15-24 months, with full productivity still a couple of quarters away. No explanation was given for either shift.Geojit's pivot to recurring assets is working. Its credibility on cost guidance is not.
-
Advit Jewels gave two different timelines for its 30-store rollout on the same call
Management said Fincot committed to 30 stores in 2 years, then 3 years, and also contradicted itself on margins. No quantified FY27 guidance offered.
Inconsistency On the July 2026 call, management first said Fincot committed to 30 stores in the next 2 years, then later said 3 years — no explanation. Also, management first said margins are fixed regardless of product or cost, then said moving to B2C should improve margins, without reconciling the two.Advit's opportunity is real, but the same-call contradictions on store rollout and margins make the guidance hard to buy.
-
Solara Active's debt-free target turned net debt-free without explanation
May call: 'internal target of making Solara debt-free by FY29'. July call: 'net debt-free...certain debt on the books'. Credibility question on the balance-sheet plan.
Inconsistency In May 2026 management said Solara would be debt-free by FY29. In July 2026 that became net debt-free, with debt remaining on the books. The change was not explained.Solara's base business is healing, but the debt-goalpost shift turns a clean story into a credibility question.
-
Trishakti entered wind energy, reversing January's explicit rejection
CEO said no wind in Jan 2026; Jul 2026 announces wind as strategic growth. Borrowing cost jumps from 4-6% to 8.5-9.75%, unexplained.
Inconsistency In January 2026 Trishakti's CEO ruled out wind energy because yields were unattractive. In July 2026 he announced wind as a strategic growth initiative, claiming yields similar to the current fleet. Management also cited borrowing costs of 4-6% in April 2026 but reported an average of 8.5-8.75% in July 2026 — a material discrepancy not reconciled.Strong quarter, but four strategy reversals in six months make future guidance harder to underwrite.
-
Mahindra Holidays delays Theog by a year, extends portfolio exits
The flagship Theog Himalayan resort is now targeting Q3/Q4 FY28, three to four quarters behind schedule. Portfolio pruning also slipped. Keystone premiumization and resort demand remain strong.
Inconsistency Theog Resort timeline moved from H2FY27 to Q3/Q4 FY28, a three-to-four-quarter delay; management cited a luxury-positioning study. Portfolio exit schedule also extended: earlier expected to finish in Q1/Q2, now another 300-400 keys over three quarters ending FY28.Underlying demand is strong, but Mahindra Holidays keeps pushing its big bets out. Credibility on timelines is the new risk.
-
Cipla raised war-cost impact to 1-2% after earlier downplaying
South Africa weakness recast from destocking to lost tender; peptide launch plan narrower. All three signals challenge the margin recovery story.
Inconsistency In May 2026, Cipla said the near-term war impact would not be meaningful. In July 2026, it quantified the cost at 1-2% of revenue and cited it as a material margin drag. Separately, South Africa weakness was attributed to channel destocking in January but now to a lost tender with ongoing impact. The peptide launch plan also narrowed from three additional assets to one.Cipla's margin recovery story depends on guidance that keeps shifting. Trust requires consistency, not revisions.
-
UTI AMC pivots on product strategy without explaining why
Three months after limiting launches to core diversified categories, management now plans sectoral debt funds, a reversal that raises questions about guidance reliability and product boundary discipline.
Inconsistency In April 2026, management said it had deliberately stayed away from sector and thematic funds for 3-5 years and would continue that principle. In July 2026, it disclosed plans to launch a balanced hybrid fund and sectoral debt funds, a product strategy expansion without explanation.UTI's product strategy flip is small in itself, but the failure to address it makes every other directional promise harder to believe.
-
UCO Bank moved its ECL transition date and stretched its provisioning plan without explanation
The transition was pushed from June to April 2027, and provisioning for the remaining 40% buffer was spread over 4-5 quarters, a shift from earlier guidance suggesting faster build-up.
Inconsistency In January 2026, management said ECL would go live in June 2027 with near-complete provisioning by then. By July 2026, the date became April 1, 2027, and only 60% of the buffer was ready, with the rest to be built over 4-5 quarters. The change in timeline and pace was not explained.UCO Bank's numbers are good. Its credibility on provisioning timelines just got a dent it didn't address.
-
Radio City's digital revenue share halves without reconciliation
Digital revenue fell from 8% to 4% of total revenue between May and July 2026 calls, contradicting prior guidance — while radio profit surged on cost cuts.
Inconsistency Digital revenue share was reported as 8% in both the February and May 2026 calls. In July 2026, management said it was 4% without explaining the change or reconciling the definition.Healthy profit growth is real, but the digital revenue flip-flop and idle cash raise questions that go beyond the quarter.
-
CIE Automotive's new 'no forward guidance' policy contradicts its own April capex forecast
Management told investors it does not make forward-looking statements as a matter of policy, just months after giving explicit India capex guidance and while continuing to provide growth and margin targets in the same call.
Inconsistency In April 2026 management guided for India capex of ₹4-5 billion for CY26. In July 2026 management stated it is not its policy to make forward-looking statements, yet in the same call gave guidance for India growth of 12-15% over two quarters, Europe market decline of 2-3%, and margin recovery timeline. The policy reversal reduces the reliability of management's forecasting framework.CIE Automotive's disclosure flip-flop undermines confidence in its guidance, even as operational levers remain intact.
-
Madhusudan Masala outsources production after years of claiming in-house manufacturing
Q1 revenue rose 34.5% to ₹98.3 cr, but the company disclosed a shift to outsourcing without explaining the change, while a prior blended-spices target was quietly dropped.
Inconsistency In November 2023 and November 2024, management stated that all spice production was conducted entirely in-house. In July 2026, it disclosed that it is currently outsourcing a significant amount and will not be entirely in-house even after the Sonasara expansion. Separately, in November 2024, management targeted blended spices reaching 10% of sales within two years; by July 2026, blended spices remained at 5% and management said moving from 5% to 20% was not a priority.Madhusudan's Q1 was strong, but the manufacturing pivot and abandoned target call management's word into question.
-
Adani Power ups capacity target to 45 GW, cuts capex, changes Bangladesh receivable story
Record Q1 with PAT up 47% masks three inconsistencies: expansion target raised without rationale, capex cut 8% without explanation, and Bangladesh receivables now all revenue despite earlier dispute process.
Inconsistency Expansion target raised from 42 GW to 45 GW without incremental execution or funding detail; FY27 capex cut ~8% to ~₹23,000 cr despite no program change; Bangladesh receivable characterization shifted from potentially disputed to all revenue without reconciliation.Adani Power's numbers are strong, but its guidance credibility has three question marks – and management didn't address any of them.
-
BPCL's Bina project commitment quadruples without explanation, as Q1 loss hits ₹3,962 cr
Marketing losses and geopolitical disruption drove a standalone loss, but a bigger concern is the jump in committed capex from ₹6,800 cr to ₹30,000 cr.
Inconsistency The Bina petrochemical and refinery expansion project's commitment escalated from ₹6,800 cr (Aug 2025) to ₹30,000 cr (Jul 2026), with progress only from 14% to 30.7%. Separately, the wind program shifted from 100 MW split between MP and Maharashtra with LOAs issued to only MP capacity secured, without explanation.A why is lacking on the Bina commitment—BPCL's Q1 loss may be temporary, but the capex puzzle is not.
-
Bansal Wire absorbed gas shock but reversed steel cord and land strategy
Q1 revenue rose 25% as margin recovered to ₹7-8 per kg, but steel cord qualification was pushed out 6-8 months and Sanand land sale plans were softened — two reversals without explanation.
Inconsistency Steel cord approval: In Apr 2026 management said only a sample remained before sale; in Jul 2026 it described a four-stage trial process expected to take 6-8 months. Sanand land: In Apr 2026 management said the remaining 50% would be sold for cash; in Jul 2026 it said only part might be sold, with the rest retained for expansion. Neither reversal was explained.Bansal Wire absorbed the gas shock. The strategy reversals are the open question.
-
Gandhar Oil says exceptional spreads will persist – after previously calling them unsustainable
Q1 EBITDA margin hit 16.2% versus 5.1% a year ago, but management's hopeful tone on sustainability contradicts earlier guidance of 5.5-6% as normal.
Inconsistency Three months ago Gandhar management guided for 5.5-6% EBITDA margins and INR7.8-8 per liter gross spread as sustainable levels. After reporting 16.2% EBITDA and INR28,145 per kiloliter spread, they said they are hopeful of maintaining those levels for the whole year, without reconciling the difference or explaining why exceptional spreads should persist.Gandhar's record quarter is real, but the guidance flip leaves the market to guess what 'normal' really means.
-
Vardhman Special Steel's greenfield plant timeline shifted again – now FY27 or FY30
The company's greenfield project timeline has moved from July 2029 to a fuzzy target of either FY27 or end-FY30, creating material uncertainty around its largest capex.
Inconsistency In Jan and Apr 2026, management said the greenfield plant would commission in July 2029. In Jul 2026, opening remarks said FY27, but Q&A pushed it to end-FY30 with significant revenue only in FY31. These statements are unreconciled.Strong demand and solid execution in the existing business; the greenfield timeline mess is the one weakness that needs fixing.
-
SRF's HFC expansion contradicts prior guidance; AI timelines shift
Q1 FY27 is the best ever quarter with EBIT up 61% to ₹1,116 cr, but management's stance on HFC capacity and AI commercialization contradicts what was said six months ago.
Inconsistency In January 2026, management said SRF had no additional HFC capacity to put up; in July 2026, it referred to commissioning a new HFC plant in Odisha without reconciling the two statements. Also, in January 2026, an AI registration was said to have happened and a launch was on track for the coming year; in July 2026, management called the registration process 'still early' and said the innovator world would remain cautious, reducing visibility into the AI revenue ramp.A record quarter can't mask the gap between what management says and what it does. On HFC and AI, the road ahead looks different from what was painted.
-
Shoppers Stop opened Intune stores in Q1 despite H1 pause promise
Two Intune stores opened during the quarter, contradicting May 2026 guidance; premium portfolio contribution reported at 22% after earlier calls cited 69%, with no explanation for the change.
Inconsistency In May 2026, management stated Intune would not add stores in H1 and needed operational stability. In Jul 2026, two Intune stores opened in Q1, with no explanation for the override. Separately, premiumization contribution was reported as 69% in May 2026 but 22% in Jul 2026, a 47-point gap with no changed definition.Shoppers Stop is turning around, but the premiumization metric shift and the Intune opening override make you wonder what else has changed.
-
Schaeffler India's export guidance contradicts itself; capex jumps without explanation
Management shifted export targets from 5-10% to 10-12% to 15-20% in six months, then denied giving guidance. Capex flagged at ₹675 cr, up from ₹400-500 cr plan, with no revised budget.
Inconsistency Export guidance shifted from 5-10% (Feb 2026) to 10-12% (Apr 2026) to 15-20% (Jul 2026), then management said it never gave specific growth guidance. Capex plan was ₹400-500 cr in Apr 2026, but Jul 2026 implied ₹675 cr for the year, without explanation.Schaeffler's numbers are good, but its guidance discipline is not. Two contradictions in one call make the rest of the story harder to trust.
-
AYE Finance tightened underwriting this quarter. Last quarter it said it would relax it.
Approval rate shrunk to 45% from a planned reopening toward 55%, even as PAT jumped 144% and gross NPA improved to 4.5%.
Inconsistency In March 2026, AYE Finance management said approval rates would reopen from 40-43% toward 55% in the coming year, adding 8-10% growth. In July 2026, management said the approval rate had shrunk to 45% and that it was keeping the policy tight, without explaining why the previously expected reopening was abandoned.AYE Finance delivered a strong quarter, but the underwriting reversal without explanation undermines faith in management's forward guidance.
-
Nippon Life India raised expense guidance after three quarters of 15% messaging
Expense growth guidance jumped from 15-16% to 18-20% in the July call, a revision management attributed to technology and brand investment without bridging the old number.
Inconsistency In the April 2026 call, management guided expense growth of about 15-16% YoY ex-ESOP, and had said 15% plus/minus 1-2% for several quarters. In the July 2026 call, management corrected that to 18-20% growth, citing continued technology and brand investment, with no quantification of why the prior guidance no longer held.Record market share meets a credibility gap on costs. The guidance revision needs a bridge, not just a correction.
-
MPS acceptance metric flip clouds guidance; Unbound synergy timeline slips
Q1 revenue up 20.4%, EBITDA margin jumps to 34.3% — but two inconsistencies from prior calls raise credibility questions on the long-term story.
Inconsistency In May 2026, management described a 52% manuscript acceptance lift versus a 32% industry baseline. In July 2026, they described 52% as the absolute acceptance rate against the same baseline — a materially different claim. Separately, the Unbound synergy timeline, previously guided as a clear path, is now 'early stages' with no committed timeline.Strong operational quarter, but two guidance inconsistencies test narrative credibility. Close the gap.
-
Adani Green Energy misses its curtailment resolution timeline
Management had said prior-year EBITDA losses would not recur. Three months later, curtailment still impacts EBITDA by 5-7%, with relief now pushed to end of calendar year.
Inconsistency In April 2026, management said prior-year EBITDA losses of ₹1,300-1,500 cr from curtailment were not expected to recur. In July 2026, curtailment still impacts EBITDA by 5-7% and resolution is pushed to end of calendar year. The earlier expectation was not met.Adani Green is executing on the ground but missing on its own timeline. The curtailment flip makes its guidance a lagging, not leading, indicator.
-
Kirloskar Pneumatic's FY27 guidance implies slower growth than promised
Management maintained ₹2,100 cr target despite Middle East delays, but math shows growth of just 13.5-16.7% from the FY26 range — a quiet downgrade with no explanation.
Inconsistency In January 2026 management guided for a return to 20% top-line growth from FY27. In July 2026 it maintained ₹2,100 cr revenue guidance for FY27, which implies only 13.5%-16.7% growth over the FY26 range of ₹1,800-1,850 cr, a significant downgrade without explanation.Kirloskar Pneumatic's numbers are solid, but its guidance math doesn't add up to its earlier promises.
-
Tips Music employee cost run-rate reversed, profit outlook cloudy
Management said in April that higher employee costs were a one-time provision. Now it says the Q1 level will continue. Combined with a content budget raise and YouTube Shorts delay, guidance credibility is under strain.
Inconsistency In April 2026 management said higher employee costs were a Q4 provision and would not be the new run rate. In July it said employee costs would remain at the Q1 level, implying a permanent increase with no explanation for the change.Tips Music's guidance is only as good as the consistency behind it. This quarter, it's fraying.
-
South West Pinnacle's Oman contract: 10 years or 11? Two discrepancies.
Record order book of ₹761 cr drove Q1 revenue up 54% and EBITDA margin to 24.2%, but two inconsistencies in the Oman story – contract duration and capital commitment – raise questions about guidance reliability.
Inconsistency Oman contract duration was described as 11 years in May 2026 but as a $125 million 10-year contract in July 2026. Separately, the INR 15-20 crore investment commitment for Oman was replaced by a 'depends on reserves' statement, with no explanation for the change.The order book is record-high and Q1 delivery is strong. But the inconsistent Oman guidance tests credibility. Watch for a clean-up on the next call.
-
Welspun Special.Soln's utilization target slipped from 2 years to 5. No one reconciled the numbers.
Q1 EBITDA rose 2.5x but steel utilization is 40-45%, well below the 80-85% guided for 2 years ago. The timeline has now stretched to 3-5 years.
Inconsistency In Jan 2026, management said hitting 80-85% utilization in 2 years was still the agenda. In Jul 2026, it reported steel utilization at 40-45% and framed 80-90% utilization as a 3-to-5-year focus. The export weakness explanation does not reconcile the lower current level or the materially longer timeline.Welspun Special.Soln's value-over-volume strategy is working on profits, but the utilization guidance is losing credibility.
-
Medplus freezes capex, reverses private label trajectory
Board-approved adjacent projects paused after shareholder backlash; private label mix slipped from 22% to 20% as employees over-pushed equivalents.
Inconsistency In May 2026 management said private label incentive restructuring was working and would return to promised growth. In July 2026 it said employees had over-pushed private label, customers were put off, and it was pulling back. Separately, FY27 margin guidance of 5.7-5.8% was deferred after Q1 EBITDA of 3.5%.Medplus's capex freeze and private label reversal are defensible individually, but together they undercut the strategy story the street was buying.
-
D.P. Abhushan drops explicit revenue guidance, pivots to volume target
In May CEO Vikas Kataria guided ₹4,800 cr for FY27; in July the same CEO would only say 10% volume growth, leaving value to gold prices.
Inconsistency Revenue guidance replaced by volume target: In May 2026 management guided for FY27 revenue of ₹4,800 cr and FY28 of ₹5,500 cr. In July 2026 the CEO said only 'We are aiming for 10% volume growth' and refused to reaffirm the revenue numbers. Gold exchange contribution also fell from 35-40% to ~25% without explanation.D.P. Abhushan traded the clarity of revenue targets for the hedging of volume guidance. That’s a downgrade for investors.
-
Smartworks trims FY27 revenue guidance to 28-30%, down from 30-35%
The co-working operator also revised its capex assumption upward and retention recovery remains elusive, raising questions about long-term guidance credibility.
Inconsistency Smartworks lowered its FY27 revenue growth guidance to 28-30% from the 30-35% CAGR described in Aug 2025 and the '30%-plus' aspiration in Nov 2025, without explaining the change. Management previously said the ₹1,350/sq ft capex level would stabilize, but now says it rises 5% annually due to inflation. The anticipated retention recovery above 80-85% has not materialized; retention remains at 74%.Smartworks is compounding well, but the guidance reduction and changed assumptions test whether management's word is as firm as its balance sheet.
-
Sunteck Realty's Dubai investment figure doesn't add up across two calls
Management told investors in April the Dubai investment implied ₹312-325 cr; now says it is not more than ₹200-225 cr, without explanation. Meanwhile, Q1 pre-sales rose 20%.
Inconsistency In April 2026, management said the Dubai investment was AED70 million plus an additional AED60 million, totaling AED130 million, which at ₹24-25/dirham implied roughly ₹312-325 cr. In July 2026, management stated the investment was not more than ₹200-225 cr. The variance was not explained.Sunteck's cash-flow engine is humming, but a gap in its Dubai investment number is a hole in the story that needs filling.
-
JSW Energy's connectivity insulation claim hits reality as 300 MW curtailment, 400 MW delay
Management had said it was 'absolutely insulated' from connectivity challenges. This quarter, 300 MW faced curtailment and a 400 MW Rajasthan project's connectivity slipped from July to September-October without explanation.
Inconsistency Management previously claimed insulation from connectivity challenges and expected curtailment to end by July 2026. In the July 2026 call, 300 MW was still under T-GNA and facing curtailment, while a 400 MW Rajasthan project's connectivity moved from end-July to September or October without explanation.JSW Energy's gigawatt buildout is impressive, but the widening gap between promises and reality on connectivity and debt targets is a concern.
-
Capital Infra Trust cuts FY28 DPU growth forecast, lowers tax-free mix
Management now expects DPU to rise 7-10% in FY28 vs earlier 'at least 10%', and tax-free portion revised to 20-25% from 25-30%.
Inconsistency In May 2026, management guided FY28 DPU growth of 'at least 10%'; in July 2026 it narrowed that to 'roughly 7-10%'. Similarly, the FY27 tax-free distribution mix was lowered from 25-30% to 20-25% without a clear explanation.Capital Infra Trust's guidance revision is a minor number with a major signal: management's forward statements should now carry a wider uncertainty band.
-
Servotech's capacity timeline slipped by 18 months; order book language also shifted
The company promised a new plant by Jan 2025; now construction is just starting. The order book is no longer 'firm on paper' after earlier citing ₹600 cr in hand.
Inconsistency In October 2024, management committed that a new manufacturing facility would be fully operational before January 2025. In July 2026, they said a new Haryana plant's construction is just starting — a delay of at least 18 months with no explanation. Separately, earlier calls cited an order book of over ₹600 crore, but in July 2026 management said the channel-partner model does not create a firm order book on paper and that order sizes are shrinking.Servotech's capacity bottleneck is real, but the bigger problem is the gap between what management said before and what it says now.
-
Tinna Rubber's TPO and RCB commissioning delayed, yet FY27 revenue guidance raised
Milestones for pyrolysis and recovered carbon black plants slipped one to two quarters, but management lifted combined revenue estimate to ₹50-60 cr without explaining the contradiction.
Inconsistency In May 2026, Tinna Rubber management guided TPO stabilization by Q1 FY27 and RCB full operation by Q3 FY27 with combined FY27 revenue of ₹50-55 cr. In July 2026, TPO stabilization moved to Q3 FY27 and RCB commercial sales to Q4 FY27, yet the revenue estimate was raised to ₹50-60 cr, now 7-10% of FY27 revenue. The basis for higher revenue on delayed timelines was not explained.Tinna Rubber's record margins buy some patience, but the widening gap between TPO/RCB timelines and revenue targets tests credibility.
-
Adani Total Gas's ₹1,500-crore EBITDA guidance is already unreconciled
In April management guided for ₹1,500 cr EBITDA and said 85% of CNG volumes were protected. In July it reported 40% APM allocation, 50% spot purchases, and no margin recovery timeline.
Inconsistency In April 2026, management guided for ~₹1,500 crore EBITDA and said 85% of CNG volumes were covered by protected APM/contracts. In July 2026, it reported only 40% domestic APM/NWG allocation and 50% spot purchases, with no reaffirmation of the EBITDA target or timing for margin recovery.ATGL's volume story is intact; its margin story is now a question of trust.
-
Mastek's backlog hit $310M, but Middle East guidance reversed and margin target slipped
A $25M Salesforce AI deal fueled order-book growth, but management contradicted its Jan 2026 Middle East outlook and declined to reaffirm the 16.5-17% EBITDA range after a 15.4% quarter.
Inconsistency In Jan 2026, Mastek said Middle East would start sustainable growth in one quarter and that 16.5-17% EBITDA was achievable. In Jul 2026, it said Middle East faced severe headwinds with uncertain predictability and reported 15.4% EBITDA, declining to reaffirm the margin range.Strong backlog, weaker credibility. Mastek needs to deliver on both Middle East and margins to rebuild trust.
-
Anthem Biosciences reversed its no-guidance stance on FY27, now commits to growth
After refusing to give FY27 guidance in May, management now says it will deliver growth numbers — supported by a 60% order book but a soft Q1 that leaves a lot riding on back-end loading.
Inconsistency In February and May 2026, Anthem's management declined to provide FY27 guidance, saying it couldn't determine the trajectory. In July 2026, despite a soft Q1, management shifted to an affirmative commitment to deliver its FY27 growth numbers. The change in posture was not explained.The order book supports the confidence, but the guidance reversal needs more explanation than management gave.
-
Adani Energy Solutions' C&I capacity drops from 1,400 MW to 350 MW
Management didn't explain the apparent 75% reduction in third-party consumer capacity, and the energy solutions revenue is now called long-term PPA after earlier describing it as merchant.
Inconsistency In April 2026, management said it had ~1,400 MW of third-party consumer capacity. By July 2026, the stated C&I customer base was only 350 MW, an apparent 75% reduction, not explained. Also, energy solutions revenue shifted from merchant to long-term PPA without reconciliation.A 1,400 MW to 350 MW drop without explanation makes the platform's reported scale and earnings quality hard to underwrite.
-
Atlanta Electricals delays 400 kV and 765 kV milestones as revenue surges 48%
Record order book of ₹3,117 cr provides visibility, but two key technology qualification timelines have slipped without explanation.
Inconsistency In May 2026 management said the first 400 kV transformer would be ready for short-circuit testing by quarter-end. In July 2026 it said manufacturing would commence in two months with testing in early next quarter. Similarly, the 765 kV tech tie-up was expected to close in 'next couple of months' in May; now it's targeted for Q2 with no reason given for the delay.Atlanta's record orders show demand, but twice-slipped timelines on 400 kV and 765 kV test management's execution narrative.
-
Infobeans added healthcare as a vertical — after saying it hadn't
Q1 revenue rose 33% to ₹153 cr but margin slipped to 23%; management gave no FY27 revenue guidance and contradicted its own vertical focus statement.
Inconsistency In April 2026 Infobeans said BFSI and storage/virtualization were its only proactive verticals. In July 2026 management first said 'still only two sectors' then added healthcare. The pivot was unexplained.Infobeans' Q1 was strong but the missing growth guide and contradictory vertical focus make the story less clean than the top line suggests.
-
Canara Robeco's AUM grew 7% this quarter. Its internal target was 20%.
The gap between a 20% minimum internal benchmark and 7% reported growth is the largest since the target was set. Management did not say whether the target has been withdrawn.
Inconsistency In January 2026, management set a 20% minimum year-on-year AUM growth benchmark. The July 2026 call reported 7% growth, with no acknowledgment or explanation of the gap. The cost-to-income range was also tightened from 40-50% to below 40% (38-42%), and a six-month SIP turnaround promised in January has not materialised as discontinuations remain elevated.Canara Robeco's profit growth is fine. The 7% AUM growth against a 20% internal target is not. That silence is the story.
-
E2E Networks withdrew MRR guidance; Blackwell ramp drove 334% revenue surge
Q1 revenue hit ₹1,568 M, EBITDA margin 75.2%, but management scrapped explicit MRR guidance and changed GPU deployment description versus prior call
Inconsistency In Apr 2025, management targeted MRR of ₹35-40 cr by Mar '26; in Jul 2026, it refused to provide MRR guidance and did not reconcile the previous target. Also, prior call described a 2,048-GPU lot as H200s; latest call said 2,024 Blackwells went live without clarifying if it's the same lot, a replacement, or additional.E2E's Blackwell ramp is real, but the withdrawn MRR guidance and silent GPU revision leave a credibility gap that the growth numbers alone cannot fill.
-
IHCL's Frankfurt opening delay and strong domestic demand shape Q1
Consolidated revenue up 15% to ₹2,419 cr, but Frankfurt contribution slips from June to September with no clear cause. Domestic RevPAR grew 14% as portfolio crossed 645 hotels.
Inconsistency In May 2026, IHCL expected Frankfurt to open in June and contribute during FY27. In July 2026, management said the impact would begin only in September, acknowledging a delay without specifying a cause.IHCL's domestic engine is firing, but international headwinds and a delayed Frankfurt opening mean the full-year narrative depends on execution, not just demand.
-
Aavas Financiers cut FY27 guidance and reversed home loan strategy
Management reduced the FY27 disbursement growth target to 22-23% from 25%+, flipped on market-share commentary, and forecast spreads below 5%, despite a strong Q1 execution.
Inconsistency In February 2026, management targeted 25%+ FY27 disbursement growth and said it had never chased market share. In July 2026, it cut guidance to 22-23% and said regaining home loan market share is the primary aim. It also abandoned its earlier spread outlook of 5.20-5.25%, now forecasting sub-5%.Aavas delivered a strong quarter but a confusing strategic picture. The guidance cuts and contradiction on market share need explanation.
-
Bajaj Auto raised its export target without explaining the revision
Export target raised to 250,000/month without reconciling 14% jump; KTM-Triumph store milestone missed — record quarter absorbed 4.5% inflation.
Inconsistency In May 2026 management targeted exports at 220,000 units per month for the quarter. In July 2026 it raised the target to beyond 250,000 per month, a roughly 14% revision without explicit reconciliation. Separately, management had guided for over 100 joint KTM-Triumph stores by March 2026 but reported only about 90 by July, with no explanation for the shortfall.Record quarter, but the unreconciled export target and missed store milestone undercut guidance credibility.
-
Navkar's port capex plan drops from ₹15,000 cr to ₹13,000 cr without explanation
The FY27-28 capex allocates ₹13,000 cr to ports, down from ₹15,000 cr guided in January 2025. No bridge was provided.
Inconsistency In January 2025, management said port investment would be approximately ₹15,000 crore by FY28. In July 2026, the FY27-28 capex plan allocates only ₹13,000 crore to ports — about 13% lower — without reconciling the earlier figure.Navkar's port pipeline is surging, but a 13% capex cut without explanation clouds the narrative.
-
Transformers & Rectifiers relaxed its 24-month order policy — and changed its story on inventory
The Rs 6,630 crore order book looks strong, but management's shifting explanations on order timelines and inventory build raise execution and credibility questions.
Inconsistency In April 2026, management ruled out orders beyond 24 months. In July 2026, it disclosed a 30-month order as an exception without explaining the policy override. Separately, the cause of elevated inventory shifted from 'no major impact' from West Asia to citing the geopolitical situation.TARIL's order book is a strength, but management's shifting explanations make guidance harder to trust.
-
Bajaj Healthcare gave three different timelines for its peptide plant on the same call
Management said the facility would commission by Q4 2027, then later said commercialize in Q4 of this year, then reverted to Q4 2027 — leaving investors unsure when Semaglutide revenue will actually flow.
Inconsistency In the opening remarks, management targeted peptide facility commissioning by Q4 2027. In the Q&A, management said the plant would commercialize in Q4 of this year (which would be March 2027, earlier than Q4 2027). Later in the same Q&A, management reverted to commercialization in the last quarter of 2027. No explanation was provided for the discrepancy.Bajaj Healthcare's peptide bet has big upside if the timeline holds, but the call's contradictions make it hard to rely on.
-
Shyam Metalics lowered FY27 growth guidance by 10 ppt. No explanation given.
Revenue and EBITDA growth cut from 'close to 30%' to 'more than 20%' between May and July calls, while stainless steel run-rate forecast doubled without reconciliation.
Inconsistency FY27 growth guidance reduced: 'close to 30%' in May 2026 to 'more than 20%' in July 2026. Stainless steel run-rate forecast increased from ₹300 cr/month to ₹600-700 cr/month without explaining changes in scope or assumptions.Shyam Metalics delivered a solid quarter but undermined it with unexplained guidance cuts. The 10ppt growth reduction demands a better answer than prudence.
-
ABSL AMC's alternate AUM jumps 6x without reconciliation; passive growth halves without explanation
Management reports PMS/AIF assets at nearly ₹2 lakh crore, up from ₹32,663 crore in January, attributing growth to ESIC/EPFO – but the prior call had already disclosed the ESIC mandate separately.
Inconsistency In January 2026, management reported PMS/AIF/Advisory AUM of ₹32,663 crore, explicitly excluding the ESIC mandate. In July 2026, it reported nearly ₹2 lakh crore in PMS and AIF assets, attributing the jump to ESIC and EPFO, without reconciling the scope change. Separately, passive quarterly average AUM fell from ₹38,600 crore (28% YoY growth) to ₹34,000 crore (14% YoY), without explanation.ABSL AMC's AUM milestone is real, but the inconsistent definition of alternate assets and unaddressed passive slowdown make the growth story harder to trust.
-
Paytm's UPI MDR story flipped from dramatic upside to immaterial in six months
Management now says UPI MDR won't materially change the business, contradicting January's 'dramatically change' forecast. The reversal is unexplained.
Inconsistency In January 2026, management said UPI MDR 'will dramatically change' the business with substantial acquiring-side upside. In July 2026, they said MDR 'will not change materially' and should be excluded from discussion. No explanation was given for the shift.Paytm's operating recovery is real, but the unexplained UPI MDR flip-flop leaves a credibility gap that no EBITDA margin target can fully bridge.
-
Mahindra Logistics freight forwarding flips from growth to 39% drop
Q1 FY27 PAT of Rs 25.4 cr shows turnaround, but management did not explain why freight forwarding fell from 33% growth to 39% drop in six months.
Inconsistency In January 2026, management described freight forwarding as growing 33% YoY, driven by improved trade flows and a diversified customer base. In July 2026, revenue fell 39% to Rs 45 cr, blamed on customer attrition during a transition and geopolitical crisis – without reconciling the prior narrative.Mahindra Logistics is turning around in contract logistics and express, but the freight forwarding narrative reversal needs an honest bridge before the turnaround story is complete.
-
GSM Foils contradicts itself on Lamitube, receivables and debt
Q1 revenue surged 86% to ₹96.9 cr, but management pivoted from Lamitube to ROPP caps without explanation, stretched receivables to 75–80 days, and sought an additional ₹40–50 cr of debt — all contradicting prior guidance.
Inconsistency In May 2025, GSM Foils guided for Lamitube capex by Q2/Q3 as a margin driver; in Jul 2026, it highlighted ROPP caps as key diversification with no mention of Lamitube. Receivables cycle widened from a guided 50–55 days to 75–80 days. Debt comfort rose from ₹30 cr to seeking an additional ₹40–50 cr without reconciling the earlier limit.GSM Foils is growing fast, but its strategy flip-flops make the growth harder to trust.
-
Bluestone quietly cut its marketing spend target to 4.5% from 6%
Management had repeatedly guided for 6% of revenue as the ongoing level; the new plan calls for a decline to 4.5-4.6% over five years without acknowledging the reversal.
Inconsistency In April and January 2026, management said marketing spend would remain at approximately 6% of revenue. In July 2026, they projected a decline to 4.5-4.6% over the next five years, a material reduction not explained.Bluestone's numbers were strong, but the marketing-spend reversal erodes faith in its guidance. Credibility matters more than a beat.
-
Rallis India reverses seed growth guidance and pricing stance in single quarter
Cotton seeds are now unlikely to grow, and price pass-through is only partial — two reversals that make the FY27 margin roadmap less certain.
Inconsistency In January and April 2026, management said cotton would be the highest-growth seed crop and expected high double-digit seed revenue. In July 2026, management said cotton is unlikely to grow and seeds grew only 6%. In April, management said it was passing on full cost increases; in July, it said pass-through was partial or absent in some areas, with most growth now dependent on volume.Rallis's seed and pricing reversals undermine the FY27 margin story. Volume needs to deliver what pricing cannot.
-
Regency Fincorp reversed PPI license status and digital lending terms
PPI license went from 'NOC received, approval imminent' to 'applied for, 4-5 months'; digital lending interest rate moved from 24% to 30% flat without explanation.
Inconsistency In May 2026, management stated it had received RBI NOC for the PPI license and expected approval in the coming quarter. In July 2026, management said it had only applied for the license and expected approval in 4-5 months, a material regression. Separately, digital lending pricing changed from 24% flat interest with a six-month tenor to 30% flat with four-month tenor, affecting revenue assumptions.Regency's secured lending is scaling fast, but the unexplained reversals on PPI and digital lending terms erode confidence in its guidance.
-
Karur Vysya Bank quietly lowered its NIM guidance floor by 5 bps
The bank's FY27 NIM range shifted from 3.75%-3.8% to 3.7%-3.8% between the May and July calls, without acknowledging the change. Q1 results were strong, but management warned against extrapolating.
Inconsistency The May 2026 call guided NIM at 3.75%-3.8% for FY27. The July 2026 call narrowed the range to 3.7%-3.8%, a 5-bps reduction in the floor, while stating it was not changing full-year guidance. The shift was not explained.Strong Q1 masked a quiet guidance downgrade and a deliberate slowdown signal. KVB's discipline is admirable, but the near-term earnings picture just got fuzzier.
-
SG Mart cuts margin outlook for profiles and solar structures from prior FY27 ranges
Steel profile EBITDA guidance reset to ₹3,000-4,000/ton from ₹5,000-8,000, solar structures to ₹2,500-3,000 from ₹3,000-5,000; B2B trading plan quietly dropped from 500,000 tons to optional. Service center volumes surge 160,000 tons.
Inconsistency Management lowered its FY27 EBITDA margin guidance for steel profiles from ₹5,000-8,000/ton to ₹3,000-4,000/ton and for renewable structures from ₹3,000-5,000/ton to ₹2,500-3,000/ton, attributing the drop to purchased coated steel. Separately, the B2B trading volume target of 500,000 tons (₹50 cr EBITDA) was abandoned; Q4 delivered just 17,000 tons. Neither pivot was reconciled with prior commitments.SG Mart's manufacturing pivot is real, but the margin reset and abandoned trading plan show guidance that cannot be relied on without a track record.
-
Rossari Q1 record revenue but margin miss, guidance flip on EO and EBITDA floor
Revenue jumped 28% to ₹697 cr, but EBITDA margin slipped to 11.6% from 12.5%, and management lowered the near-term margin floor without reconciling to prior guidance.
Inconsistency In April, management guided FY27 EBITDA margins at 12-13% and said EO supply was stable. In July, margins came at 11.6% and management agreed that could be the base, and described EO as constrained, contradicting the prior stance without explanation.Record revenue growth, but margin guidance whiplash raises questions about the base the company is building from.
-
Two Oberoi Realty launches missed prior schedules; NCR 360 North booked ₹8,000 cr but timing slipped
The NCR project that overshot expectations also missed its own timeline, while Adarsh Nagar shifted multiple quarters. Consistency on launches is weak.
Inconsistency 360 North was supposed to launch in Q4 FY26 per the July 2025 call; the July 2026 call said it was intended for Q1 FY27 but missed by a few days. Adarsh Nagar was left open for Q4 FY26 in July 2025; now management hopes for Q3 FY27. Neither shift was explained.NCR validates the expansion thesis, but launch credibility needs repair before guidance is taken at face value.
-
PSB trims NIM guidance, shifts ECL stance as RAM growth accelerates
NIM target cut to 2.60-2.65% from 2.65-2.70%; ECL provisioning moves from capital charge to P&L without reconciliation. RAM advances hit 60% of book, driving 19.4% credit growth.
Inconsistency NIM guidance: In April 2026 management expected NIM to reach 2.65%-2.70% by year-end. In July 2026 the target was 2.60%-2.65%, lowering both midpoint and ceiling with no explicit reconciliation. ECL provisioning: In April 2026 management said the ₹600-800 crore ECL impact would be absorbed from capital. In July 2026 it booked ₹150 crore as a P&L provision without explaining the change in treatment.PSB's RAM growth is real, but two strategy switches – on NIM guidance and ECL provisioning – make forward earnings harder to trust.
-
Vimta Labs won't define capacity utilisation after giving 80-85% in January
Management refused to give a percentage for new facilities this call, despite having cited 80-85% utilisation for the EMI/EMC chamber just six months ago.
Inconsistency In January 2026, management said the current chamber is running at 24/7, 80% - 85% utilization. In July 2026, management said it would not define capacities as percentages at any point of time, creating an unexplained change in disclosure basis.Vimta's biologics milestone is real, but a shifting disclosure stance doesn't inspire confidence in the capex story.
-
UltraTech's India Cements cost capex triples to ₹2,000 cr without explanation
The cement giant reported a record Q1 with 13.1% volume growth, but a three-fold jump in the India Cements cost-improvement program raises questions on capital allocation clarity.
Inconsistency India Cements' cost-improvement capex rose from ₹601 cr committed in January 2026 to about ₹2,000 cr in July 2026. The expansion in scope or estimate was not explained, changing the return profile of the turnaround.Record Q1 shows UltraTech's strength; the unexplained tripling of India Cements capex needs a why.
-
UltraTech's record quarter clouded by India Cements timeline slip
India Cements ₹1,000/ton EBITDA exit pushed from Q4 FY27 to Q4 FY28; cost-improvement capex triples to ₹2,000 cr without explanation.
Inconsistency India Cements EBITDA target of ₹1,000 per ton slipped from Q4 FY27 (Jan 2026 guidance) to Q4 FY28 (Jul 2026 guidance). Separately, the cost-improvement capex commitment rose from ₹601 cr to ~₹2,000 cr, more than three times the earlier figure, without scope or plan clarification.UltraTech's record quarter is clouded by a strategy gap on India Cements that management has not yet closed.
-
Can Fin Homes reversed its sales team expansion plan, run-down spikes
Q1 disbursements beat guidance but run-down hit ₹1,857 cr; sales headcount plan dropped without explanation, credit cost guidance cut to 10 bps.
Inconsistency In April 2026 management planned to add 60 salespeople, but in July it said additional staffing would come from existing teams. The change was not explained and could affect sourcing capacity and growth.Can Fin Homes delivered on disbursements but borrowed against its own credibility with an unexplained sales team reversal.
-
Globus Spirits reversed its ethanol offtake story. May said weak. July said sticky.
Management also delayed West Bengal re-entry, misstated net debt by ₹33 crore, and abandoned earlier cost-neutrality guidance on input inflation.
Inconsistency In May, Globus Spirits said it shifted from ethanol to ENA due to lower offtake by oil marketing companies. In July, management called ethanol offtake 'very sticky' and 'fairly consistent' without explaining the reversal. West Bengal re-entry, promised in Q1, is now dependent on approvals plus 60 days. Net debt was restated from ₹627 crore to ₹660 crore, a 5% difference with no reconciliation.Globus Spirits delivered a clean quarter, but the growing gap between what management says and what it does is the real story.
-
Axis Bank's NIM hits cycle bottom as CFO departs and Axis Finance pivot remains unexplained
Q1 NIM of 3.5% is the trough, per management, but CFO Puneet Sharma's exit without a named successor and a silent strategy shift on Axis Finance stake sale cloud the outlook.
Inconsistency In Dec 2025, management said exploring a stake sale in Axis Finance was 'not off the table'. In Jul 2026, when asked about increasing the Max Life stake, management discussed only internal evaluation, with no mention of the Axis Finance process—signaling a potential strategy shift without explanation.Axis Bank delivered a clean NIM trough quarter, but the CFO departure and a strategy pivot without a why leave too much unsaid.
-
Kotak Mahindra Bank's NIM guidance flip-flop erodes credibility
Six months ago management guided for a moderate NIM increase in Q4. This quarter NIM was flat and they refused to provide any guidance, with no explanation for the reversal.
Inconsistency In Jan 2026, management guided for a moderate NIM increase in Q4 FY26 citing deposit repricing and CRR benefit. In Jul 2026, NIM was flat at 4.53% and they declined to give any forward NIM guidance, stating it's 'very difficult to give guidance'. No explanation was provided for the failed projection.Kotak delivered strong earnings but weaker guidance credibility. Three reversals in six months demand a 'why' – and it wasn't provided.
-
Yes Bank holds SR recovery guidance despite sharp deceleration; gold loan pivot surfaces
Management maintains ₹800-1,000 crore SR recovery target for FY27 even after Q1 gains of just ₹86 crore, and reconsiders gold loans it had deliberately deprioritized six months ago.
Inconsistency SR recovery guidance unchanged despite actuals collapse: In January 2026 management guided for ₹800 crore annual SR recoveries; in July 2026 they maintained the same range even though Q1 FY27 gains were only ₹86 crore vs ₹555 crore in Q3 FY26, acknowledging JC Flowers controls execution but offering no rationale for sustained confidence. Gold loan strategic pivot: The bank deliberately deprioritized gold loans in January 2026; in July 2026 management said they may build capabilities if the product offers opportunity, without citing any market trigger.Yes Bank's core business is healing fast, but the SR guidance disconnect and gold loan pivot test the market's faith in what management says.
-
Reliance Jio IPO not imminent after all, as management contradicts prior timeline
In January Reliance said the Jio IPO was 'imminent' and would happen in 'the next few months'. In July, it deflected on timing. The company also reversed guidance on gas availability and quietly introduced a 2X EBITDA retail target.
Inconsistency Jio IPO timing: In Jan 2026 management said the IPO was 'imminent' and should happen in 'the next few months'. In Jul 2026, when asked about satellite investment specifics from the DRHP, management said it's 'not possible to speak about at this point in time', indicating a stall. Gas availability policy: In Apr 2026 management said a policy circular diverting gas to city gas distribution had been 'rolled back'. In Jul 2026 it cited the same regulation as a headwind forcing the refinery to use more expensive fuels. Retail growth outlook: In Apr 2026 management urged looking past short-term growth volatility. In Jul 2026 it introduced a specific ambition to double absolute EBITDA over the next two to three years, not previously disclosed.Reliance's quarter was strong, but three strategy reversals in one call make guidance harder to trust.
-
JSW Steel abandoned 50% captive coking coal target it set two months ago
Captive coking coal guidance dropped from 50% by FY31 to ~30% by CY2028; BF3 commissioning delayed one quarter. Both shifts went unacknowledged.
Inconsistency In May 2026, JSW Steel management guided for 50% captive coking coal integration by FY31, citing the MdR Mozambique acquisition. In July 2026, the CFO projected only around 30% captive by CY2028 and dropped the FY31 target entirely. The retreat was not explained.JSW Steel's Q1 was strong. But the unacknowledged retreat on captive coal and the BF3 delay are the real story.
-
South Indian Bank's corporate book u-turn mars NIM recovery story
Management had repeatedly guided to reduce corporate loans to 30-33% of advances. Instead, it opportunistically grew to 40% and will keep doing so, calling it a 'one-time adjustment'.
Inconsistency Management had consistently stated a strategic priority to reduce the corporate loan book to around 30-33% of total advances (May 2026 and Oct 2025 calls). In the Jul 2026 call, management indicated they opportunistically grew the corporate book to 40% and will continue to do so, describing the growth as a 'one-time adjustment' without reaffirming the previous medium-term target.The NIM story is real. The strategy story is not. On guidance credibility, South Indian Bank gets a yellow card.
-
Borosil Renewables halves rooftop solar revenue target to ₹36 crore
First-year target cut 50% from ₹75 crore, while 600 TPD expansion revenue pushed to FY28, despite strong core glass margins of 35%.
Inconsistency Rooftop solar first-year revenue target was slashed from ₹75 crore to ₹36 crore. The 600 TPD expansion commissioning timeline shifted from a hinted Q4 FY26 sales to revenue recognition only from April 2027.Borosil's core glass business is shining, but the rooftop solar pivot is off to a slow start and expansion revenue is a year away.
-
Heritage Foods' ice cream facility hit 40% utilization, the lower end of its own 40-45% guidance
Management projected 40-45% capacity utilization for the new facility in its first year. It reported 40% as a successful ramp without acknowledging the prior range.
Inconsistency In January 2026, Heritage Foods guided for 40-45% capacity utilization for its new ice cream facility in the first year. In July 2026, management reported reaching 40% and called it a successful ramp-up, without referencing the higher end of the prior projection.A record quarter, yes, but guided milestones are slipping. The flush didn't flush and the ice cream facility hit only the low end.
-
5paisa says revenue has been flat for 3 years, then promises acceleration
Management raised ₹468 cr, rebuilt its platform, and now asks investors to trust that growth will resume from Q2. Five quarters of flat revenue say otherwise.
Inconsistency In Jan 2026 management cited 'robust growth of 24% QoQ' in notional ADTO. In Jul 2026 an analyst noted revenue has been 'almost flat for the last 3 years' and management did not dispute it, calling Q1 a 'one-off' and promising acceleration without a catalyst. The contradiction between prior acceleration claims and current stagnation is unexplained.5paisa needs to show that the platform pivot is more than a promise. Q2 will tell.
-
Menon Bearings brake margin hits 25% after 12-14% guidance. New target: 20%.
Record Q1 with 40% revenue growth and 60% EBITDA jump. But management's prior 12-14% brake margin guidance is now discarded for a 20% sustained target.
Inconsistency In Jan 2026 management guided for 12% brake EBITDA margins in FY27, with 18% aspirational for next year. In May 2026 they said 12-14% was sustained. In Jul 2026 they reported 25% actual margin and signaled a new target of 20%.Menon Bearings delivered a record quarter. Its guidance revisions, on brakes, revenue, capex, and ex-works, make the forward view harder to trust.
-
Muthoot Capital cuts FY27 AUM guidance by ₹300 cr with no explanation
The NBFC's AUM target fell from ₹4,500 cr to ₹4,200 cr in two months, even as asset quality improved and funding costs dropped.
Inconsistency In May 2026, Muthoot Capital guided to AUM of 'close to ₹4,500 crores' for FY27. In July 2026, that was revised down to 'around 4,200 crores' without explanation. Separately, risk-based pricing was said to be already operational in October 2025 but is now described as 'looking to implement'. And EV co-lending, previously continued, has been completely closed.Muthoot Capital's numbers are improving. Its guidance has a credibility problem.
-
Sterling and Wilson's record order book masks a domestic order miss
Despite highest-ever unexecuted order value of Rs 13,000 crore, management cut FY27 revenue growth guidance to 10-15% after domestic orders came in at Rs 6,400 crore vs guided Rs 20,000+ crore.
Inconsistency Management guided for over Rs 20,000 crore in domestic orders in Q4 FY26 and Q1 FY27 but only Rs 6,400 crore materialized. FY27 revenue growth guidance was cut from 15-20% to 10-15% without explaining why project delays were more than seasonal.Sterling and Wilson's record order book buys time, but the domestic market miss and guidance cut erode trust in management's market call.
-
Himadri gave three conflicting signals this quarter
Birla Tyres timeline extended, anode facility location switched, partner name changed — all without explanation, even as Q1 PAT rose 27%
Inconsistency Three discrepancies emerged: 1) Birla Tyres revenue target timeline extended from 4 years to 4-5 years without explanation. 2) Anode material facility location changed from Mahistikry to Budge Budge. 3) Birla Tyres operating partner changed from Dalmia Refractory to Gallon Refractory. None were explained.Himadri's Q1 numbers look strong, but three unexplained contradictions in a single call make its guidance harder to underwrite.
-
Brahmaputra Infrast. flip-flopped on order book execution timeline
In June, management guided that 60% of ₹1,600 cr order book would execute in FY27. In July, it called that a 'misunderstanding' and reverted to a 2.5-3 year timeline.
Inconsistency Order book timeline reversal: June 2026 call guided 60% execution in FY27; July 2026 call reversed, calling it a 'misunderstanding' and reverting to 2.5-3 years. Promoter share pledge narrative changed from being linked to past debt to specifically tied to OCCPS. New real estate project launch delayed from 'next four to five months' to 'end of the year'.Three reversals in one month make Brahmaputra Infrast.'s guidance hard to underwrite.
-
Angel One's margin guidance range has shifted. Its AMC strategy has too. It hasn't explained either.
Management went from 40-45% to 45-50% on margins and from passive-only to exploring active funds, both without acknowledging the change in approach.
Inconsistency In the January 2026 call, Angel One management guided for 40-45% standalone operating margin for the broking and distribution business. In the July 2026 call, when asked about that target, management first said no change, then cited a different range of 45-50% as the guidance that remains intact. Separately, management previously stated it was focused on passive-only for its AMC with 'nothing to talk about on the active side.' Now it says it is exploring ways to expand beyond passive. The shifts were not explained.Angel One's numbers are solid. Its guidance credibility is not.
-
SSWL reverses steel wheel narrative, adds Rs 150 cr capex
After years of calling steel a laggard and exiting Maruti business, management now says steel is growing and capacity is sold out, while capex jumps to Rs 600-650 cr.
Inconsistency Steel wheel narrative flip: In Jan 2026, management described steel as low-margin and deliberately exited Maruti business. In Jun 2026, they said steel is now growing and capacity is sold out. Capex guidance also rose from Rs 460 cr to Rs 600-650 cr, including a previously unmentioned Rs 150 cr brownfield expansion.SSWL's new steel story has potential, but the flip-flops on strategy and capex demand proof, not just words.
-
HDB Financial delays unsecured business loan growth by one quarter without explanation
Q1 FY27 PAT rose 38% YoY and NIM hit 8.35%, but management pushed the expected book growth inflection on unsecured business loans from Q1-Q2 to Q3 without clear reasoning.
Inconsistency In the Jan 2026 call, management said unsecured business loan growth would return 'in a couple of quarters', implying recovery by Q1-Q2 FY27. In the Jul 2026 call, they said disbursements may start improving but book growth would only come from Q3 onwards, a delay of at least one quarter without explaining what changed.HDB Financial's execution is strong, but the unsecured book timeline delay undercuts management's visibility claims.
Call-monitor notes
-
SBFC Finance prioritizes margin over growth as household stress rises
Q1 AUM rose 27% with NIM at 10.6%, but management flagged conversion drop, sub-Rs10 lakh stress and raised ECL buffers pre-emptively.
SBFC Finance is trading volume for margin. Prudence pays off in a downturn, but the conversion rate must stabilise before the strategy is fully endorsed.
-
Meesho cut logistics costs again, but new bets cost ₹39 cr
Q1 NMV rose 2.0% QoQ, cost per order fell ₹1, and Horizon 2 losses hit ₹39 cr. Management reiterated 25% long-term NMV CAGR while capping new initiative spend at ₹200 cr for FY27.
Meesho's cost machine works. The top-line compound is the open variable.
-
Cyient pushes 15% EBIT margin target to H1 FY28 as DET growth stalls
DET constant-currency revenue declined 0.5% sequentially, and the 15% EBIT margin goal is now delayed by at least a quarter, despite strong transportation and DLM performance.
Cyient's delayed margin target makes the H2 DET revenue recovery the only catalyst in sight. Execution is no longer optional.
-
Ujjivan Small Fin Bank raises FY27 ROA guidance to 1.8-2.0% after strong Q1
Q1 ROA of 2.2% already tops the new range; management sees sustained growth via secured lending, but flags capacity spend and sector headwinds.
Ujjivan's guidance raise is a vote of confidence, but Q1's 2.2% ROA is a high bar; watch cost and gold loan execution.
-
Waterways Leisure reports 105% load factor as demand outstrips capacity
Q1 net profit ₹22.8 cr on ₹190 cr revenue, but fuel costs ate ₹14 cr from EBITDA; fleet expansion with Cordelia Sky due October
Demand is surging, but fuel costs and opaque guidance keep the earnings story incomplete.
-
Vishal Mega Mart's volume holds up despite inflation, eyes 3,000 small stores
Q1 revenue ₹3,727 cr, up 18.7%, with 10% same-store sales growth. Management sees a national small-format opportunity of nearly 3,000 stores.
Resilient volumes and a credible store expansion story; watch the data slips and wage cost creep.
-
United Spirits' Smirnoff surge masks state policy drag and cost inflation
Smirnoff hit nearly ₹250 crore NSV in Q1, while P&A ex-Maharashtra grew volume 6.4%; UKFTA opens Scotch access but visibility is delayed until October.
Smirnoff is the spark, but the real story is whether inclusive premiumization can sustain momentum against policy drag and cost inflation.
-
Waaree Renewables pivots to T&D, margin dilution accepted as cost of scale
Q1 revenue jumps 53% to ₹924 cr on solar EPC strength, but the narrative is all about the APS acquisition and a ₹20,000 crore T&D pipeline that management says will fuel multi-year demand.
Waaree's T&D pivot is a long-term infrastructure play. The near-term margin dilution and debt are the price of admission; the next test is whether the pipeline converts into orders.
-
HPCL's underrecovery tsunami: Rs 26,000 cr gap, debt at Rs 72,000 cr
Q1 GRM of $24 was overwhelmed by marketing losses; management expects recovery via HRRL, but Q&A revealed a slower ramp than flagged earlier.
HPCL's recovery hinges on HRRL and under-recovery relief; both are uncertain. The debt peak is not yet visible.
-
Arvind Fashions direct channels hit 62% as Q1 shows structural margin gains
Revenue up 15.5%, EBITDA margin improves 44 bps, and D2C pivot accelerates with online B2C surging 38%.
Arvind Fashions' D2C pivot is delivering margin gains — the question is how much external headwinds will push back.
-
Gabriel's Jupiter recasts it as group vehicle; margins slip
Q1 standalone margin fell to 8.4% on commodity costs and delayed pass-through, even as the ₹2,231 cr HL Mando acquisition positions Gabriel for braking, steering and ADAS.
Gabriel is buying its way into a bigger story, but margins need to catch up before the market gives full credit.
-
Aurum Proptech posts third straight profitable quarter as Housing integration gains traction
Revenue rose 71% YoY to ₹112 crore; adjusted EBITDA positive for third quarter. Management targets Housing profitability in 4-6 quarters, with an internal ambition of 3-4.
Aurum's third straight profit is a milestone, but the real test is Housing's turnaround over the next four to six quarters.
-
ACE posts record Q1 but withholds FY27 growth target as inflation bites
Revenue up 19% to ₹836 crore, EBITDA margin up 12 bps despite 140 bps gross margin drop from steel and commodity inflation; management refuses to quantify full-year growth before September.
ACE's record Q1 is less a growth story than a holding pattern. Inflation is dictating every margin decision, and management is unwilling to forecast until it knows who blinks first, customers or costs.
-
Sonam delivers clock explosion: revenue up 22%, pre-sales hit Rs 450 cr
EBITDA margin expands to 25% from 22% as debt-to-equity falls to 0.5; order book of Rs 2,500 cr provides visibility but management again declines numerical guidance.
Sonam's clock explosion is real, but without numerical guidance the visibility remains a narrative.
-
Dynamic Cables Q1 volume stalls at 5-6%, revenue growth driven by pricing
Record Q1 revenue (up 33% YoY) masks a volume growth of just 5-6%, with the balance from higher aluminum pass-through. Order book flat, cycle shortens.
Dynamic Cables' record revenue is a pricing story, not a volume one. The stall demands evidence of acceleration before the growth target can be trusted.
-
ICICI Bank Q1: Dominance accelerates, guidance stays range-bound
Loan growth of 19.6% YoY was broad-based, NIM stable at 4.4%, but management refused to give a full-year loan target and estimated normalized credit cost at 50 bps.
ICICI Bank's Q1 was strong, but the refusal to guide on loan growth and the 50bps normalized credit cost temper the picture.
-
Ramco Systems turns EBITDA positive, guided for quarterly progression
Q3 FY24 EBITDA at ₹1.4 cr, order book up 28% QoQ, but revenue growth marginal at 2% YoY and management refuses to give margin targets
A credible turnaround signal, but the profit trajectory needs a gear shift in revenue to be sustainable.
-
Federal Bank's CASA ratio jumps to 32.2%, driving NIM expansion
CASA balances grew 18.3% YoY, outpacing deposits; NIM up 13 bps sequentially. Credit cost came in at 41 bps but management held guidance at 50-60 bps citing macro risks.
Strong CASA-led NIM expansion and credit cost beat, but the decision to hold guidance unchanged signals macro caution outweighs near-term comfort.
-
Hexagon Nutrition margins double as clinical nutrition market opens up
Maiden earnings call shows EBITDA margin jumping to 13.83% from 12.33%, as management lays out the structural growth story in fortified foods and therapeutic nutrition.
Hexagon Nutrition has the market tailwind. Growing the branded share will determine the multiple.
-
Ceat holds pricing line as rubber surge crushes gross margin to 33.9%
Q1 gross margin fell 575 bps QoQ despite 11% price hikes; management vows to hold prices until 40-41% normal margin returns, even as Q2 raw material costs are locked at inflated levels.
Ceat is pricing for margin recovery, but the rubber wave may not crest until H2.
-
WeWork India occupancy hits 84.9%, revenue up 28.5%
Occupancy surged 8+ points, member base grew 30%, and EBITDA rose 69% as managed office and Member Services add new revenue layers.
WeWork India is compounding with occupancy gains and a new revenue layer, not just riding the flex cycle.
-
D.B. Corp print ad growth of 10% drives margin gain despite circulation slide
Q1 print advertising up 10% to ₹4,320 mn; EBITDA margin rose 250 bps to 26.1%. Circulation falls to 38 lakh copies but management sees floor.
D.B. Corp's print resilience is real, but structural circulation decline and a long digital monetization path keep the growth story bounded.
-
Emmvee Photovoltaic posts record production and higher margins in Q1
Integrated model drives cell utilisation to 83%, DCR mix above 50% and EBITDA margin of 35% as order book reaches 9.9 GW.
Emmvee's integration payoff is real. The 6 GW expansion will determine how much richer the returns get.
-
Newgen's annuity growth accelerates; implementation drag remains.
Annuity revenue grew 14% to ₹254 cr, SaaS jumped 40%, but implementation revenue fell 25% YoY; management targets 20% EBITDA margin for FY27.
Newgen's annuity engine is humming, but the implementation drag is a temporary story that needs to prove out in Q2-Q3.
-
Sai Silks faces wedding drought as Adhik Maas hits Q1, but holds FY27 guidance
Q1 revenue flat at ₹375 cr, same-store sales down 7.5% as inauspicious month deferred purchases; management reaffirms 12-15% growth for full year, betting on H2 recovery.
Sai Silks is betting H2 wedding dates will fix Q1's Adhik Maas hangover. That bet needs the monsoon and consumer sentiment to cooperate.
-
GTPL Hathway's HITS platform drives margin recovery path despite near-term profit dip
Operating margin guided to 25% in FY27 from current 22% as HITS bandwidth savings and ACT acquisition benefits kick in by H2; net profit fell ₹8 cr due to depreciation and finance costs.
The HITS hangover is a near-term drag, but the margin bridge it builds is real. Execution in H2 will determine whether the market buys the story.
-
Polycab posts record Q1 PAT on 39% revenue growth, cable boom intact
Wires & cables revenue up 39%, FMEG surges 71%, but export weakness and working capital normalization warrant caution
Polycab's cable franchise is firing on all cylinders, but the export headwind and working capital normalization are two clouds on an otherwise clear horizon.
From the earnings calls
Summarised straight from the company's earnings-call transcript, same day. We cite the call and link the transcript; we don't reproduce it.
-
MobiKwik posts Q4 profit, invests in merchant growth engines
Core payments and lending are profitable, but reinvestment into merchant payments will keep near-term margins modest.
-
Aurionpro misses Q4 targets on MEA war, hyperscaler delay; CEO vows resilience
A disappointing quarter with costly missteps, but medium-term drivers remain intact.
-
Dixon sees near-term margin pressure but bets on Vivo, IT hardware ramp
Near-term headwinds from PLI sunset and memory inflation will pressure margins, but backward integration and new verticals provide long-term growth runway.
-
Nexus Select Trust targets 9% DPU growth in FY27 on strong demand
Management conservatively guided 9% DPU growth but sees upside from consumption and leasing spreads.
-
V-Guard Q4 revenue up 14%, PAT up 23%; cost inflation a concern
Strong Q4 performance masks brewing commodity cost pressure from West Asia war; management is confident on margin resilience but cautious near-term.
-
Neuland Labs posts record Q4 but flags lumpiness ahead
A stunning quarter, but management warns the 40%+ EBITDA margin is not a new normal; lumpy growth is the reality.
-
Berger Paints expects volume growth to hold as price hikes offset inflation
Proactive pricing and cost control keep margins in guided band despite input inflation
-
Tata Power posts record PAT above Rs 5,000 crore in FY26, eyes 25,000 crore capex in FY27
A record year across all segments, but renewable execution and transmission delays remain the key watchpoints.
-
Sagility posts strong Q4, guides for low double-digit growth in FY27
Strong execution and seasonal tailwinds drove a beat, but FY27 guidance reflects cautious optimism amid AI headwinds.
-
Dr. Reddy's Q4 hit by ₹453cr lenalidomide hit, but base business grows double-digit
Management struck a cautiously optimistic tone, citing strong base business momentum and semaglutide approvals, but the massive lenalidomide shelf-stock adjustment blindsided analysts.
-
FirstCry expects FY27 growth to outpace FY26 as delivery initiatives gain traction
Management's delivery and offline bets are paying off, but diaper margin wars remain a drag.
-
Zuari Industries sees debt halving to ~₹700-800cr as Dubai project cash flows in
The sugar and ethanol beat is overshadowed by the real progress on deleveraging — the Dubai payoff is finally in sight.
-
Aarti Pharmalabs expects 15-18% revenue, EBITDA growth; CDMO to lead with 40-50% jump in FY27
Management's growth guidance hinges on CDMO ramp-up and Xanthine capacity addition, but margin headwinds from raw material inflation persist.
-
Orchid Pharma sees pricing recovery, targets 12% EBITDA margin for FY27
Worst of cephalosporin pricing cycle may be behind, but execution on new platforms remains key.
-
Amara Raja Q4 revenue up 16% but margins hit by raw material costs
Strong revenue growth tempered by cost pressures and muted exports, with margin recovery hinging on further price hikes.
-
Aia Engineering posts record profit but future hinges on mining solution scale-up
Record earnings from currency and mix, but the mining solution breakthrough remains a promise, not a pipeline.
-
Jubilant Ingrevia posts best quarterly revenue in 14 quarters, flags growth acceleration ahead
A solid quarter with strong execution, but CDMO ramp-up and agro recovery are critical for sustained 20% EBITDA growth.
-
Camlin Fine maintains FY27 guidance despite geopolitical headwinds
Management held firm on double-digit EBITDA margin guidance despite a sharp Q4 hit from shipping disruptions and raw material inflation, betting on vanillin and blends growth.
-
Cosmic CRF wins Supreme Court nod for Amazon, Q4 revenue jumps 78%
Supreme Court clearance for Amazon acquisition is the game-changer, but execution and RDSO license delays remain risks.
-
Rupa & Company sees volume-driven growth, guides to 9-10% EBITDA margin
Athleisure rebound and price hikes boost margins but competitive pressures persist.
-
Salzer Electronics targets 9.5% EBITDA margin in FY27 after commodity cost pressures
Management's margin recovery hinges on price hikes passing through, but execution risks remain.